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PROPOSITIONS 
• The statement by Hill et al. that NifL contains 3 FAD molecules per tetramer, and 
the statement by Hefti et al. that the NifL PAS domain contains 2 FAD molecules 
per tetramer, are both incorrect. 
Hill, S., S. Austin, T. Eydmann, T. Jones, & R. Dixon (1996) Azotobacter vinelcmdii NifL is a 
flavoprotein that modulates transcriptional activation of nitrogen-fixation genes via a redox-
sensitive switch, Proceedings of the National Academy of Sciences of the United States of 
America 93, 2143-2148. 
Hefti, M. H., C. J. G. Van Vugt - Van der Toorn, R. Dixon, & J. Vervoort (2001) A novel 
purification method for histidine-tagged proteins containing a thrombin cleavage site, Analytical 
Biochemistry 295, 180-185. 
• The nomenclature SI / S2, PAS-A / PAS-B, PAS domains / PAC motifs, and LOV 
domains should be abandoned, and instead the name 'PAS fold' should be used. 
This thesis, chapter 7. 
• NifL is a hemo-flavo-protein. 
• When performing large-scale modelling of protein sequences, the time it takes to 
perform the calculations is never the rate limiting step. 
• Crystallisation is art, crystallography is science. 
Making a model of a horse from photographs does not tell how fast it will run. 
Gutfreund, H. & J. R. Knowles (1967) The foundations of enzyme action, Essays in Biochemistry 
3, 25-72. 
This thesis, chapter 7. 
The graduate school Experimental Plant Sciences sends emails which, according to 
their own definition, can be classified as SPAM. 
"If you set your e-mail programme to prevent you from SPAM, it will refuse messages to great 
numbers of recipients. Since EPS-NEWS is distributed to several hundreds of addresses it will 
also be refused", EPS email newsletter 251,10 February 2003. 
The European Union divides the EC contribution to research infrastructures into 
arbitrary classes. By doing so, they give a false representation of the total amount of 
money really contributed to the field of nuclear physics. 
Enhancing Access to Research Infrastructures 1998-2002, technical review of IHP-ARI contracts 
(2003). 
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Wanderers in the land of Osten Ard are cautioned not to put blind trust in old rules and 
forms, and to observe all rituals with a careful eye, for they often mask being with 
seeming. 
The Qanuc-folk of the snow-mantled Trollfells have a proverb. 
'HE WHO IS CERTAIN HE KNOWS THE ENPING OF THINGS WHEN HE IS ONLY 
BEGINNING THEM IS EITHER EXTREMELY WISE OR EXTREMELY FOOLISH: NO 
MATTER WHICH IS TRUE, HE IS CERTAINLY AN UNHAPPY MAN, FOR HE HAS PUT 
A KNIFE IN THE HEART OF WONPER. ' 
More bluntly, new visitors to this land should take heed: 
'AVOIP ASSUMPTIONS.' 
The Qanuc have another saying: 
"WELCOME STRANGER. THE PATHS ARE TREACHEROUS TOPAY.' 
THE PRAGONBONE CHAIR - Tad Wi l l iams 
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CHAPTER 1 
General Introduction 
into the Field of 
Nitrogen Fixation, 
MfL, 




Biological N2 fixation involves the enzymatic reduction of N2 to ammonia. The 
ammonia produced can subsequently be incorporated in the organism by enzymatic 
means, to be used for the growth and maintenance of the cell. N2 fixation is unique to 
bacteria. Animals and plants that need to fix N2 must do so in association with bacteria. 
An understanding of biological N2 fixation is essential to elucidate the dynamics of the 
global nitrogen cycle (Figure 1.1). With the exception of water, nitrogen is generally 
considered to be the most limiting nutrient for growth of plants in their natural 
environment. The capability of fixing N2 is recognised as a process of great agronomic 
importance, and a variety of leguminous plants and some non-leguminous plants can 
obtain their nitrogen from the air by symbiotic association with micro-organisms. 
Figure 1.1 The global nitrogen cycle. 
The nitrogen cycle symbolises the transformations undergone by the element 
nitrogen (N) on this planet (Figure 1.1). The bottom section shows the assimilation of 
nitrogenous living matter (mainly protein) from inorganic nitrogen compounds (nitrate, 
nitrite, and ammonium ions) during growth of plants and their consumption by animals. 
They then return to the soil as a result of decay and putrefaction of plant and animal 
material. The upper section shows the loss of nitrogen to the atmosphere from nitrates, 
and its return to the cycle by the process known as nitrogen fixation. The element 
nitrogen is an essential constituent of all organisms, and in nearly all agricultural areas of 
this planet, biological productivity is determined by the availability of inorganic nitrogen 
in the soil. 
Nitrogen fixing bacteria, diazotrophs, are capable to convert N2 to NH3 by electron 
reduction and protonation of gaseous dinitrogen. Nitrogenase is the enzyme complex in 
diazotrophs responsible for this N2 fixation. The biosynthesis of NH3 is determined by 
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15 to 20 different nitrogen fixation (nif) gene products'541. The nif genes may be carried 
on plasmids, as is the case in most Rhizobium species. More commonly, these nif genes 
are located on the major chromosome in free-living and associative nitrogen-fixing 
bacteria. These genes and their genomic arrangement is rather conserved in the various 
diazotrophs1541. Comparison of the physical and genetical maps of w/-specific genes 
from Klebsiella pneumoniae, Azotobacter vinelandii, Rhodobacter capsulatus, 
Bradyrhizobium japonicum, and Clostridium pasteurianum reveals that spacial 
arrangements of the individual nif genes are not always conserved at the interspecies 
level. For example, nifW and nifL genes are located adjacent to each other in K. 
pneumoniae and A. vinelandii, but not in R. capsulatus15^. The primary products of the 
nitrogenase genes are not capable of catalysing N2 fixation. The products of a number of 
other nif-specific genes are required for the maturation of the nitrogenase structural 
components. 
Ammonia, the product of nitrogen fixation, is assimilated in diazotrophs by the 
enzyme glutamine synthetase (GS). In this reaction, ammonia is incorporated into 
glutamate to yield glutamine. Glutamate is regenerated by the activity of GOGAT 
(glutamate synthase). 
GS 
NH3 + L-glutamate + ATP • L-glutamine + ADP + P, 
GOGAT 
L-glutamine + a-ketoglutarate + NADPH • 2-glutamate + NADP* 
By the combined activities of GS and GOGAT, cells are supplied with glutamate and 
glutamine. Glutamate is the source of a-amino groups of all amino acid residues, and 
half the nitrogen in pyrimidine, purine and imidazole rings, and the amino group of 
adenine. These together represent approximately 90 % of all nitrogen-containing 
metabolites. Glutamine, on the other hand, provides nitrogen in amino-sugars, NAD, 
para amino benzoic acid (PABA) and the other nitrogens in purines, pyrimidines, 
histidine and tryptophan. Together, these represent about 10 % of all nitrogen-containing 
metabolites[239]. 
The activity and/or synthesis of nitrogenase in diazotrophs is inhibited by an 
abundance of fixed nitrogen compounds in the environment. In addition to 
transcriptional control of nif genes in response to fixed nitrogen, nitrogenase enzyme 
activity itself may be inhibited in the presence of ammonium. This inactivation occurs 
for instance in several nitrogen-fixing bacteria including Cyanobacteria, Rhodobacter, 
and Azospirillum[U0' 330l In the latter three organisms, the nitrogenase Fe-protein is 
modified by attachment of an ADP-ribose moiety by the DraT enzyme in cells grown 
with excess ammonium, causing nitrogenase inactivation. The ADP-ribose is removed 
by the DraG enzyme when nitrogen becomes limiting'1301. In all free-living or associative 
diazotrophs examined, excess ammonium prevents nif gene expression. 
13 
Chapter 1 
Regulation of nitrogenase {nif) gene expression in Azotobacter vinelandii is 
complicated by the fact that the organism has the ability to synthesise two alternative 
nitrogenases. Expression of all three nitrogenase systems is repressed by high 
concentrations of fixed nitrogen, and expression of the individual systems is determined 
by the metal availability. Nitrogenases require anaerobic conditions, a source of low-
potential electrons, and a large amount of ATP to reduce N2 to NH3[36, 118]. Consistent 
with the oxygen-sensitivity of these enzymes, their synthesis is repressed under aerobic 
regimes where nitrogen fixation is inhibited11151. The interrelationship of these different 
gene systems and the co-ordination of their regulation have been investigated. 
Discrimination between expression of different systems must occur either by selective 
expression of the different nifA homologues or by control of the activity of their 
products. nifA is a regulatory gene required for activation of nif gene transcription. 
In K. pneumoniae, H. seropedicae and R. capsulatus, expression of the nifA gene is 
prevented in cells grown in ammonium enriched medium'80'184' 267\ In K. pneumoniae, A. 
vinelandii, A. brasilense, H. seropedicae and R. capsulatus, the activity of the NifA 
protein is inhibited in cells grown in ammonium. In the former two, but not the latter 
three organisms, the nifA gene lies downstream from and is cotranscribed with «J/L[25]. 
In A. vinelandii and K. pneumoniae, the NifL protein is a sensor for the environmental 
status of both ammonium and oxygen supply and if either is plentiful or excessive, NifL 
inactivates NifA so that transcription of the nif genes does not occur. 
NifL 
NifL is a flavoprotein, which can inactivate NifA depending on the redox state of the 
cejj[H6,253] j ^ J ^ J ^ protein is a sensor for the environmental status of both ammonium 
and oxygen supply. If either of the latter two molecules is present, NifL inactivates NifA 
so that transcription of the nif genes does not occur. How NifL is converted from its inert 
form to an active NifA-inhibitory form in cells with ammonium (or other repressive 
fixed N sources), and conversely, how active NifL is converted to its inert form in the 
absence ammonium or oxygen, are key questions in understanding w/gene regulation in 
this nitrogen fixing member of the gamma group of Proteobacteria. 
In A vinelandii, the activation of nif gene expression by the transcriptional regulatory 
enhancer binding protein NifA is controlled by the sensor flavoprotein NifL in response 
to changes in oxygen level or the level of fixed nitrogen[116'194]. This regulation provides 
a tight control of nitrogen fixation and avoids the unnecessary consumption of energy. 
Inhibition of NifA activity occurs via direct protein-protein interactions, and requires 
stoichiometric amounts of both proteins. This is shown by immunological studies and 
the demonstration of complex formation between NifL and NifA by co-chromatography 
and the 'yeast-two-hybrid'-system[74' 1451. The formation of the inhibitory complex 
between NifL and NifA may be regulated by the intracellular ATP/ADP ratio. 
Adenosine dinucleotides promote complex formation in vitro, allowing isolation of the 
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NifL-NifA complex. Removal of the dinucleotide causes dissociation of the complex. 
The N-terminal domain of NifA and the C-terminal region of NifL potentiate the ADP-
dependent stimulation of NifL-NifA complex formation. The NifL-NifA complex is 
composed of a tetramer of NifL and a tetramer of NifA[193'1941. 
Redox potential 
-196mVatpH7.0 
C > Transcription 
ATP ADP + P, 
rreduced 
ADP 
Figure 1.2 The proposed conversion of inactive NifL to active protein forms that 
inhibit NifA (after[57]). 
ADP 
NifL is a novel redox-sensing flavoprotein that also responds to adenosine 
nucleotides in vitro, particularly ADP[116'265]. This response overrides the influence of 
redox status on NifL, and is also observed with refolded NifL apoprotein, which lacks 
the flavin moiety. The ability of NifL to inhibit NifA activity is responsive to the 
oxidation state of the chromophore, indicating that NifL is a redox-sensitive regulator. 
Redox Sensing 
The redox- and nitrogen-responsive functions of NifL are discrete[265l The oxidised 
form of NifL is competent to inhibit NifA activity, but when the flavin moiety is reduced 
with sodium dithionite, NifA activity is not inhibited1741. Gel filtration experiments with 
native NifL (residues 1-519) have shown that the protein is a tetramer in solution. The 
N-terminal domain (amino acid residues 1-284) of the NifL protein also forms a tetramer 
in solution'2651. NifL can interact with appropriate electron donors to maintain NifL in 
the reduced (inactive) state under anaerobic conditions. The redox potential of A. 
vinelandii NifL is -226 mV at pH 8.0, and -196 mV at pH 7.0, as determined by 
xanthine oxidase/xanthine in the presence of appropriate mediators. This suggests that 
NifL might be reduced by a number of different electron donors and NAD(P)H-
dependent enzymes. Re-oxidation of NifL occurs rapidly in the presence of air'155'. 
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Although NifL is maintained in an inactive state under reducing conditions in vitro, high 
NifL/NifA ratios inhibit activation under anaerobic nitrogen-limiting conditions in vivo. 
NifL is reduced relatively slowly, while re-oxidation is fast, as expected for a reduced 
flavoprotein. This provides an appropriate redox switch, allowing electron transfer to 
oxygen as acceptor at a faster rate than electron donation to NifL. The low reduction rate 
of NifL is consistent with the requirement for sustainable reducing conditions to support 
nitrogenase activity. The synthesis of nitrogenase is a large investment in biosynthetic 
capacity. A gradual switching on of nif transcription would be economic. As a result of 
the oxidation of NifL by oxygen, a fast switching off of the transcription of nif genes 
would prevent the wasteful synthesis of proteins that are otherwise destinated for 
inactivationtl55]. 
Carboxyterminal domain of NifL 
Sequence analysis of NifL indicates that the protein is composed of two domains, 
separated by a glutamine-rich flexible linker (Figure 1.3). The C-terminal domain shows 
strong homology with the histidine protein kinase family of two-component regulatory 
proteins, and binds adenosine dinucleotides[2651. 
PAC 
putative 275-299 
Sensory domain Q-linker Kinase-like domain 
< >•-*-+•< • 
Figure 1.3 The flavoprotein NifL is comprised of 2 domains, tethered by a Q-linker. 
The A. vinelandii NifL protein possesses conserved regions also found in other 
transmitter domains. Although NifL contains a conserved histidine residue at position 
304, known to be phosphorylated in other members of this family, most mutations at this 
residue do not effect the function of NifL. This implies that sensory transduction by NifL 
does not involve phosphorylation of this residue16'144' 323l Moreover, phosphotransfer to 
NifA has not been detected in vitro16' 144l 
Q-linker region of NifL 
Q-linkers are short (mostly 20 to 30 residues), hydrophilic sequences rich in 
glutamine, arginine, glutamate, serine and proline[324]. They serve as a flexible linker or a 
'coil' to connect the structurally-distinct but interacting domains of some regulatory 
proteins19' 138' 179]. The NifL Q-linker has a length of about 25 amino acid residues, 
connecting the C-terminal kinase-like domain and the N-terminal sensory domain. 
Aminoterminal domain of NifL 
NifL contains an N-terminal sensory domain, required for the redox response'2651. 
This domain shows homology to the bat gene product from Halobacterium halobium, 
which potentially has an oxygen sensing function'251. The N-terminal domain is 
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comprised of two PAS domains. Each PAS domain has a PAC like motif at its C-
terminal side. 
PAS DOMAINS 
PAS domains are ubiquitous motifs present in archaea, bacteria and eucarya'3321. PAS 
domains are found in sensor proteins and are named after homology between the 
Drosophila period protein (PER), the aryl hydrocarbon receptor nuclear translocator 
protein (ARNT) and the Drosophila single-minded protein (SIM). These domains are 
sometimes referred to as LOV domains; light-, oxygen or voltage domains'33'u'45'49'50, 
127l PAS-domains, unless most other sensory domains, are located in the cytoplasm'2871 
and include serine/threonine kinases'2311, histidine kinases'11, photoreceptors and 
chemoreceptors for taxis and tropism'2691, cyclic nucleotide phosphodiesterases'2661, 
circadian clock proteins'128'2511, voltage-activated ion channels'3161, as well as regulators 
of responses to hypoxia'1211 and embryological development of the central nervous 
system'2101. To date, most PAS domains known have a cofactor associated with this 
domain. This cofactor partly determines the specificity of a PAS domain for detecting 
input signals. 
For understanding the different mechanisms in which PAS domains work detailed 
information about their cofactor binding region is needed. In the PFAM Protein Families 
Database'131 there are currently (version 7.8) 958 PAS domains present in 607 different 
proteins. According to PFAM, a PAC motif is found at the C-terminus of a subset of 
known PAS domains, and is proposed to contribute to the PAS domain fold'3321. For 
comparison of proteins it is necessary to abandon the use of the commonly used 
annotations SI / S2[332], PAS-A / PAS-B'48'117], and PAS domain / PAC motif12311 which 
are now in use to specify sequence similarities. The LOV domain is a PAS domain as 
well. It is more important to discuss the PAS functional fold rather than sequential 
relations describing common motifs. The basis for a redefinition of the PAS structural 
fold is provided in Chapter 7. When referring to this structural element, we would like to 
suggest the term PAS fold. 
OUTLINE OF THIS THESIS 
The EU-Biotechnology project 'TASTES: Transcriptional Activation and Sensory 
Transduction; Elucidation of Structures' started as a collaboration between several 
groups in the EU: The John Innes Centre in Norwich (Martin Drummond, Ray Dixon), 
the Imperial College in London (Martin Buck), the CNRS in Toulouse (Daniel Kahn and 
Jean-Pierre Samama), the Wageningen University (Jacques Vervoort), and the EMBL in 
Hamburg (Paul Tucker and Dmitri Svergun). Within this consortium I have focussed on 
the PAS domain of the nitrogen fixation regulatory protein NifL from Azotobacter 
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vinelcmdii. A general introduction into the field of nitrogen fixation, as well as the 
biochemical importance of PAS domains is given in Chapter 1. The NifL protein is a 
flavoprotein, with FAD as the prostethic group. For studying flavoproteins, it might be 
necessary to remove this prosthetic group, or replace it with an isotopically labeled 
variant. Chapter 2 summarises the tools currently available within the field of 
flavoprotein deflavination and reconstitution. In Chapter 3 a new purification method for 
His-tagged proteins is described. This purification method makes use of the commonly 
incorporated Histidine-tag. On-column cleavage of the protein with thrombin facilitates 
the separation of the protein of interest and the His-tag. This procedure was tested for 
four different proteins, and proved to be a novel tool for protein purification. In Chapter 
4 the His-tag is again used as a tool, this time to deflavinate and reconstitute the NifL 
PAS domain protein. The method described is efficient, as shown by NMR 
spectroscopy. Crystals of the NifL PAS domain were obtained and diffracted to 3 
Angstrom resolution. Chapter 5 describes the current status of the structure elucidation 
of this domain, using X-ray crystallography. SAXS (Small-Angle X-ray Scattering) 
studies with this domain clearly showed the tetrameric state of the PAS domain. In an 
envelope, created using SAXS data, four monomelic models of the PAS domain were 
fitted, in order to elucidate the structural arrangement of these four monomers. Details 
are given in Chapter 6. In Chapter 7 the term PAS fold is introduced to denote a three-
dimensional fold present in several proteins: The photoactive yellow protein (PYP) from 
Ectothiorhodospira halophilcP1' 92\ the heme-binding domain of the Rhizobial oxygen 
sensor FixL from Bradyrhizobium japonicum[97\ and from Rhizobium melilotP90^, the N-
terminal domain of the human ether-a-go-go-related potassium channel HERG[198], the 
FMN containing phototropin module of the chimeric fern Adiantum photoreceptor149'501 
and the average NMR structure of the N-terminal PAS domain of human PAS kinase'41. 
We demonstrate that sequence comparisons alone are not sufficient to correctly annotate 
and identify PAS domains in newly discovered protein sequences. This approach leads 
to a pool of hypothetical PAS domain containing proteins. Modelling studies, and 
subsequent independent objective analysis of the 3D models give more insight into this 
intriguing family of sensory proteins. In Chapter 8 some concluding remarks are given, 
summarising the main conclusions of the preceding chapters. 
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Dvflavination and Reconstitution 
of llavoprotcins 
-Tackling Fold and Function-
A modified version of this chapter has been submitted to the 




Flavoproteins are ubiquitous proteins that are involved in many biological processes. 
In the large majority of flavoproteins, the flavin cofactor is non-covalently bound, 
providing the opportunity to replace the natural cofactor by flavin analogs. Studying 
apofiavoproteins and their reconstituted holo forms can give valuable insight in the 
thermodynamics of flavin binding, protein-flavin and subunit interactions, flavoprotein 
folding and stability, regulation processes, reaction mechanisms and redox potential 
regulation. In this review we summarise the advances made in the field of flavoprotein 
deflavination and reconstitution. Several chromatographic procedures are described that 
can be used to either deflavinate or reconstitute the flavoprotein on a large scale. These 
chromatographic procedures can combine the use of affinity tags both for the 
purification of the protein of interest as well as replacement of the protein-bound 
cofactor. Protein engineering of covalent flavoproteins provides insight into the 
mechanism of covalent fiavinylation and the rationale for this atypical protein 
modification. Understanding the flavin-apoprotein interaction is also of medical 
relevance. Several diseases are associated with mutations in human flavoprotein genes. 
These mutations may result in enzyme inactivation but can also lead to impaired flavin 
binding. 
INTRODUCTION 
Flavoproteins are involved in many biological processes and are present in all 
kingdoms of life. Flavoproteins contain a flavin prosthetic group, most often non-
covalently bound. The dissociation constants of the apoprotein-flavin complexes are 
usually between 10"7 and 10"10 M. Therefore, in most cases, it is impossible to remove 
the flavin by simple dialysis. The predominant flavin cofactors are flavin 
mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Both cofactors are 
synthesised in vivo from riboflavin (vitamin B2) by the action of riboflavin kinase and 
FAD synthetase'158'268'. The structures of riboflavin, FMN and FAD are shown in Figure 
2.1. 
The isoalloxazine ring system is the functional part of the flavin prosthetic group. It 
may undergo one- or two-electron transitions which are modulated by the surrounding 
protein structure. The versatility of one- or two-electron transitions make flavoproteins 
to be at the crossroads of cellular redoxchemistry. The electronical and geometrical 
properties of protein-bound flavin in the different redox forms, i.e. the oxidised state, the 
one-electron reduced semiquinone state, and the two-electron reduced hydroquinone 
state, are of main importance for determining flavoprotein activity. There are large 
differences in the redox potential of flavoproteins'160'271'302], ranging from -367 mV for 
nitroalkane oxidase'901 to +55 mV for vanillyl-alcohol oxidase (VAO)'841. In this paper 
we will present an overview of the field of flavoprotein deflavination and reconstitution. 
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First, however, some general considerations about the interactions between flavoproteins 
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Figure 2.1 Schematic representation of the structures of riboflavin, FMN and FAD. 
Thermodynamics of flavin binding 
The binding interaction between apoproteins and flavin prosthetic groups have been 
extensively studied. The strong and specific binding of FMN or FAD to apo-
flavoproteins is driven by the enthalpic contribution to the free energy change of 
binding'154'171'276]. The thermodynamics of flavin binding to Azotobacter vinelandii as 
well as Anabaena flavodoxin has been studied in detail'11'37'l54'235' 303l In the study of 
Carlson and Langerman'37] it was shown that the enthalpy, entropy and free energy 
associated with the binding of FAD, 8-carboxyriboflavin, or the natural cofactor FMN to 
A. vinelandii apoflavodoxin were all negative. However, striking differences in the 
enthalpy for binding FMN, FAD and 8-carboxyriboflavin (-28.3, -16.6, and -14.0 
kcal/mol respectively) were observed. It was concluded that the difference in binding 
enthalpy between FMN and 8-carboxyriboflavin results from the phosphate group in 
FMN, which binds in a predefined binding pocket in the apoflavodoxin at the N-
terminus of an a-helix. The unique hydrogen bonding network surrounding the FMN-
phosphate group stabilises the FMN-apoprotein complex'2251. This observation was 
recently corroborated by Losato et al.'154], who dissected the binding energies of the 
Anabaena apoflavodoxin-FMN complex in great detail, using a large variety of methods: 
site-directed mutagenesis, titration calorimetry, equilibrium binding constant 
determinations, and X-ray crystallography. It was shown that the contribution of the 
phosphate to the binding energy is the greatest (7 kcal/mol), that the contribution of the 
isoalloxazine is around 5-6 kcal/mol, and that the ribityl side chain contributes only 1 
kcal/mol. Both the phosphate and the isoalloxazine contribute significantly to the 
enthalpy of binding. The ionic strength of the solution does not have a large effect on the 
stability of the apoflavodoxin-FMN complex. 
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The thermodynamics of FAD binding to D-amino acid oxidase (DAAO) has been 
studied by Matteo and Sturtevant[171l The free energy of binding was shown to be 
largely independent of temperature. However, the enthalpy and the entropy of the 
binding interaction were strongly temperature dependent. In contrast to the binding of 
FMN to apoflavodoxin, where the entropy strongly opposes binding, the binding of FAD 
to DAAO is enforced by a large positive entropic contribution due to a decrease in the 
exposure of non-polar groups to the solvent and a smaller negative entropic contribution 
resulting from a tightening of the protein structure with losses in (vibrational) heat 
capacity when the coenzyme is bound. In general it is clear that (preformed) hydrogen 
bonding networks are important in flavin-binding, resulting in large negative enthalpy 
factors and that the entropic contribution can be either negative in rigid apoproteins 
(flavodoxins) or positive in more flexible apoproteins (DAAO). 
The enthalpic and entropic contributions of flavin binding are very important, when 
dealing with apoflavoprotein preparation. First the enthalpic contribution should be 
decreased in order to release the flavin from the holoprotein and second the entropic 
contribution in the preparation of the apoprotein should be decreased. The enthalpic 
contribution in flavin binding can be decreased by the addition of solutes which interfere 
with the specific interactions between flavin cofactor and apoprotein. These solutes can 
be unfolding agents (urea, guanidinium hydrochloride) which break hydrogen bonds, or 
monovalent anions (chloride, bromide) which influence protein hydration. Phosphate 
and pyrophosphate can be used additionally1631 as these compounds can bind specifically 
in the phosphate or pyrophosphate binding pocket of FMN and FAD containing 
flavoproteins, thereby diminishing the binding interaction of the flavin prosthetic group 
with the apoprotein1235' 264l Often a combined effect of urea and bromide provides the 
best result in the preparation of apoflavoproteins. In those cases where the apoprotein is 
relatively unstable it is important to positively influence the entropic contribution in the 
preparation of apoflavoproteins. Many FAD-containing flavoproteins are less stable 
when they loose their cofactor and care should be taken when removing the flavin 
prosthetic group. In several studies performed within our group we have shown that in 
those cases where the apoprotein is unstable, the best approach in preparation of 
apoflavoproteins is to bind the holoprotein covalently or non-covalently to a 
chromatographic support, thereby diminishing the entropic contributions. 
Flavin binding sites 
In flavoprotein biochemistry we deal with a combination of several factors 
influencing the different flavin binding modules. Nature facilitated the binding of flavins 
to proteins by the evolution of different flavin binding folds[62'82' 172l Within these folds, 
specific parts of the flavin molecule are recognised by different structural motifs, i.e. the 
P-P loop, the TIM barrel, the GG motif and the Rossmann fold. These structural motifs 
are characterised by their unique fingerprint sequences166'70'81'83'260'277'284'293]. Many 
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proteins that do bind FAD do not interact with FMN, and vice versa, and this is reflected 
in these fingerprint sequences. A known exception is methylenetetrahydrofolate 
reductase (MTHFR). This enzyme has a P8a8-barrel, which resembles the structure of 
FMN-binding proteins rather than FAD-binding proteins. The FAD cofactor of MTHFR, 
however, binds to a different part of the flavin binding domain compared to the barrels 
that bind FMN[1011. 
Most flavoproteins bind their cofactor in a non-covalent mode. However, in some 
flavoproteins, the isoalloxazine ring of the flavin is covalently linked to either a 
histidine, tyrosine, or cysteine residue'1851. The rationale for covalent flavinylation is not 
always clear, but for VAO from Penicillium simplicissimum it was shown that the 
covalent linkage between the C8a atom of the isoalloxazine ring of the flavin and the N3 
atom of His422 raises the redox potential of the flavin, thereby facilitating substrate 
oxidation'841. Moreover, from crystallographic analysis of non-covalent VAO variants 
and the VAO apoprotein, it could be established that the flavin binds in this enzyme to a 
preorganised binding site and becomes covalently linked to the apoprotein by a self-
catalytic mechanism'851. Members of the VAO family have a remarkable tendency for 
covalent anchoring of the flavin cofactor'831, whereas flavoproteins with a Rossmann 
fold'82' 174] clearly prefer a non-covalent flavin binding mode. Human monoamine 
oxidase'23' 24' 129] is one of the few Rossmann fold enzymes that contains a non-
dissociable covalently bound cofactor. 
A new type of flavin attachment was recently reported for the NqrB and NqrC 
subunits of the Na+-translocating NADH-quinone oxidoreductase (NQR) from Vibrio 
alginolyticus[U0, 209]. From MALDI-TOF MS analysis of proteolytic digests, it was 
concluded that in both NqrB and NqrC subunits, the FMN cofactor is attached by its 5'-
phosphate moiety to a threonine of the polypeptide chain. In agreement with this, no 
covalent flavin was detected in the efficiently expressed Thr225Leu mutant of NqrC 
from Vibrio cholerae^u\ Furthermore, from sequence comparisons it was predicted that 
this novel type of phosphoester binding between FMN and the apoprotein is conserved 
in the NQR sodium pumping systems of a number of marine and pathogenic bacteria and 
that in some of these systems the target threonine is replaced by a serine residue'1091. 
There are also flavoproteins that have more than one flavin binding site. Among 
these diflavin enzymes is NADPH-cytochrome P450 reductase (CPR) which contains 
both a FMN- and a FAD-binding domain in order to shuttle electrons from NADPH to 
the P450 heme. When removing flavin from CPR, FMN is released more easily than 
FAD[26]. The FMN-binding domain of CPR has a structure similar to flavodoxin, 
whereas the FAD binding domain relates to ferredoxin-NADP+ reductase (FNR)'314'331]. 
CPR accepts a pair of electrons from NADPH, with FAD and FMN being the port of 
entry and exit, respectively. The electrons are transferred, one at a time, to cytochrome 
P450. The two flavins are not stacked, but rather are end-on, and communicate witch 
each other through the 7- and 8-methyl groups of the xylene rings. The two isoalloxazine 
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rings are in an angle of about 150°, with the closest distance between them being about 4 
A [ 3 1 4 ] . 
Nitric-oxide synthase (NOS)'169' 249] and flavocytochrome P450 BM3[206] contain 
FAD, FMN, and heme b in one single polypeptide chain. Comparison of the structure of 
the neuronal NOS FAD/NADPH domain with CPR reveals a strict conservation of the 
FAD-binding site. This suggests that the hydride transfer mechanisms of both enzymes 
are very similar. In contrast, the FMN-binding site surface of NOS is less positively 
charged than CPR, indicating a different nature of interaction between the two flavin 
domains, and a different mode of regulation in electron transfer13291. Flavocytochrome 
P450 BM3 is a bacterial P450 system in which a fatty acid hydroxylase P450 is fused to 
a mammalian-like diflavin NADPH-P450 reductase. The enzyme is hydrophilic (unlike 
mammalian P450 redox systems) and its fusion arrangement results in the highest 
catalytic activity of any P450 monooxygenase'2061. 
Another member of the family of diflavin reductases is mammalian methionine 
synthase reductase11421, a monomeric protein of 78 kDa with both a FAD and a FMN 
cofactor'2151. In bacteria, the physiological reduction system involved in methionine 
synthesis is comprised of ferredoxin oxidoreductase and flavodoxin'88' 107' 1081. Since 
mammals lack flavodoxin, methionine synthase reductase has been recruited as electron 
donor in these systems for methionine synthase activation'2151. 
Other members of the emerging family of dual flavoproteins include sulfite 
reductase140,71,72' 219'328], and the novel reductase 1 (NR1)[221] which appears to be widely 
expressed in human cancer cell lines and, therefore, could play a potential role in the 
activation (or deactivation) of drugs used in cancer therapy. 
Artificial Flavins 
In order to gain insight into how the protein environment influences the reactivity of 
the flavin, it is desirable to remove the native prosthetic group in a, for the protein, non-
destructive way. The flavin prosthetic group can then be replaced with an artificial'94'157' 
,64, 208, 24,, 296]
 o f i s o t o p i c a U y e n r i c h e d a n a l o g [ 1 5 , 79, 86, 1,3, ,87, ,88, ,95, 196, 245, 248, 273, 309, 3,1] 
Replacement with a flavin analog should result in the (functionally active) reconstituted 
holoprotein. FMN and FAD analogs can conveniently be synthesised from riboflavin, 
either chemically12681 or enzymaticalh/1581, and can be isotopicaUy enriched'2021. 
Artificial flavins can be used to study the relative distance between particular flavin 
atoms and the protein, especially when using a series of flavins which are modified at a 
specific position, thus varying the Vanderwaals radius of the substituent. The solvent 
accessibility of the dimethylbenzene- and pyrimidine part of the isoalloxazine ring 
system can be probed by introduction of a reactive (photoactive) group'46'78'162'165'166' 
2551
. Artificial flavins can also be used to covalently link the flavin to the protein'911, or to 
determine the nature of amino acid residues in the flavin binding site'22' 46'164'168]. The 
chemical modification of the flavin molecule can have drastic influences on its 
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reactivity, spectral properties or redox potentials, thus providing the researcher with a 
powerful tool to study the enzyme reaction mechanism and/or the flavin-apoprotein 
interaction194'217'2221. 
Isotopically enriched flavins are very suitable to get a detailed view into the 
molecular and submolecular structure of the protein-bound flavin molecule. 13C and 15N 
NMR chemical shifts can reveal both n electron density and the presence of specific 
hydrogens at the carbon and nitrogen atoms investigated. 13C and 15N have a natural 
abundance of 1.1 % and 0.4 %, respectively. Therefore, the flavoprotein has to be 
reconstituted with 13C and 15N enriched flavins. This approach gives a detailed chemical 
view of a single atom (of the isoalloxazine ring system) of the flavin prosthetic group in 
the various redox states. It is possible to monitor changes during catalysis of a particular 
atom, i.e. to measure intermediates formed[308]. There is no need for the isotopic 
enrichment of phosphor atoms, since 31P, the NMR active isotope, has a natural 
abundance of 100 %. 
Medical implications 
Understanding the factors that influence the interactions between flavoproteins and 
their cofactors is also of medical importance. In 1969, it was reported that a reduced 
activity of human glutathione reductase due to a mutation can lead to nonspherocytic 
haemolytic anaemia. The abnormal enzyme had a reduced affinity for FAD, but normal 
.Km values for glutathione and NADPH. Administration of a daily flavin preparation to 
the patient had a therapeutic effect, and normal glutathione reductase activity was 
restored within a few weeks[270l 
Patients suffering from chronic granulomatous disease (CDG) carry mutations in one 
of the protein components of NADPH-oxidase, a superoxide-producing enzyme system 
involved in protection against microbial infection'2421. One of the CDG patients was 
found to carry a mutation in the FAD-binding region of the cytosolic part of the 
membrane bound flavocytochrome b558[1491. Based on mutagenesis studies of 
structurally related flavin-dependent oxidoreductases[3], it could be inferred that this 
mutation, which leads to the substitution of Thr341 by Lys, does not affect the proper 
binding of the flavin cofactor but results in impaired hydride transfer from NADPH to 
FADtl49]. This contrasts the situation with another CDG patient, where it was found that 
a single amino acid substitution (His338Tyr) in the putative ADP-binding pocket of the 
flavin-binding site of flavocytochrome b558 results in severe depletion of the FAD[327l 
NADH: cytochrome b5 reductase (b5R) is a membrane-bound flavoenzyme involved 
in the elongation and desaturation of fatty acids, cholesterol biosynthesis and 
cytochrome P450-mediated drug metabolism. In erythrocytes, a soluble form of b5R 
exists, which is functional in methemoglobin reduction. b5R deficiency manifests itself 
in two distinct ways. In type I methemoglobinemia, the patients only suffer from 
cyanosis, whereas in type II methemoglobinemia, the patients suffer in addition from 
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severe mental retardation and neurological impairment'1471. Biochemical data have 
shown that the type I mutations cause enzyme instability whereas the type II mutations 
result in complete enzyme deficiency or enzyme inactivation. From homology modelling 
with the known three-dimensional structure of porcine b5R, it could be inferred that the 
type I mutations in human b5R are located in non-essential regions and not involved in 
NADH or FAD binding. However, the other substitutions, known to cause the type II 
form of the disease, were found to directly affect the consensus FAD-binding site or 
indirectly influence NADH binding120'56]. 
MTHFR catalyses the conversion of methylenehydrofolate to methyltetrahydrofolate, 
the major methyl donor for the conversion of homocysteine to methionine. Mutations in 
human MTHFR that lead to loss of enzyme function are associated with severe 
hyperhomocysteinemia and aggressive development of cardiovascular disease'421. The 
common C677T polymorphism in the human MTHFR gene that leads to substitution of 
Ala222 by Val is associated with a milder form of hypercysteinemia'87' " I From 
structural and functional analysis of recombinant MTHFR from E. coli it was predicted 
that the Ala222Val substitution decreases the affinity of the human enzyme for FAD[101]. 
However, E. coli MTHFR is a homotetramer of 33 kDa subunits, whereas the human 
enzyme is composed of two identical subunits of 70 kDa that contain in addition to the 
catalytic domain a regulatory domain for the binding of the allosteric inhibitor S-
adenosylmethionine. To probe the FAD binding properties of the human enzyme, 
recombinant human MTHFR was expressed in a baculovirus expression system'325'. 
Biochemical analysis of the purified enzymes showed that the Ala222Val variant is more 
thermolabile and more susceptible towards monomerisation than the wild-type enzyme 
and confirmed that subunit dissociation is linked to the loss of FAD. 
Apoptosis-inducing factor (AIF) is a flavoprotein that can stimulate a caspase-
independent cell-death pathway required for early embryonic morphogenesis'52' 122l AIF 
shows NADPH oxidase activity, has a glutathione reductase-like fold and is structurally 
most similar to the ferredoxin reductase component of Pseudomonas biphenyl 
dioxygenase'1™1. To gain further insight into the redox properties of AIF, Lysl76 and 
Glu313, located near the isoalloxazine ring of FAD, were individually changed into 
alanine by site-directed mutagenesis. Both AIF variants appeared to be highly active 
when assayed in the presence of excess FAD. However, during purification Lysl76Ala 
and Glu313Ala easily lost the flavin cofactor, yielding the corresponding 
apoproteins'1701. This again demonstrates that changing a specific amino acid residue can 
considerably reduce the strength of flavin binding. 
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PREPARATION AND RECONSTITUTION OF APOFLAVOPROTEINS 
A. General remarks 
There are many methods for the preparation of reconstitutable apoflavoproteins. 
Some already exist for over 60 years, other are more recently developed. They are all 
based upon either weakening of flavin binding or stabilising the formed apoprotein. In 
theory, there are four basic principles for protein deflavination; lowering the pH, 
increasing the salt concentration, changing the solvent, and increasing the temperature. 
Because the final goal is to obtain highly reconstitutable apoprotein in high yield, the 
approach should be chosen with care. Prolonged exposure, for instance by dialysis, to 
non-native conditions, can lead to irreversible denaturation of the apoprotein formed. 
Therefore, the time needed for flavin removal should be relatively short. 
A number of different methods for the reversible removal of flavins from 
flavoproteins have been described over the years. Since each flavoprotein has its own 
physio-chemical characteristics, several strategies have been developed to find the best 
non-destructive method for the protein of interest. Initial deflavination protocols were 
based upon precipitation, partial unfolding, or dialysis of the protein[119]. More recent 
techniques focus on the binding of the protein to a chromatographic support, facilitating 
the removal of the flavin, and reconstitution of the apoprotein^2021. When studying the 
properties of apo or reconstituted flavoprotein, one needs to consider the side-effects of 
residual flavin in the endproduct. If replacement with a flavin analog is desired, residual 
natural flavin might influence the catalytic properties of the reconstituted enzyme 
considerably. The presence of residual flavin might even be more problematic when one 
wants to investigate the physical and spectroscopic properties of the apoprotein itself. 
Below we describe several apoflavoprotein preparation procedures, starting with the 
conventional (and still often used) methods. Then we turn to the growing field of 
immobilisation-based deflavination methods in which one uses specific characteristics of 
the holo flavoprotein to obtain the corresponding apoprotein. Immobilisation is achieved 
either by non-covalent or covalent binding of the holoprotein to a chromatographic 
support, and is combined with one of the common methods of flavin removal, resulting 
in less protein deterioration. 
B. Conventional methods 
In theory[119], simple dialysis will never lead to pure apoflavoprotein at physiological 
pH, since the reassociation of the apoprotein-flavin complex competes with the physical 
removal of the flavin. In practice, flavin removal by dialysis is feasible, if conditions are 
met that lead to a strongly increased dissociation constant. In 1935, Theorell was the first 
who reported that flavoproteins could be reversibly resolved into their constituents 
apoprotein and prosthetic group. To weaken the binding of the flavin, the pH of the 
dialysis solution of Old Yellow Enzyme was lowered to pH 2.7, thus releasing the non-
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covalently bound EMM'2881. A few years later it was reported that DAAO'3151 and the 
yeast en2yme of Haas'1031 could release their flavin in the presence of high 
concentrations of ammonium sulfate. Based on these initial findings a more common 
procedure for the preparation of apoflavoproteins was developed by combining a low pH 
with a high ammonium sulfate concentration'2851. Reversible precipitation methods such 
as acid ammonium sulfate and TCA precipitation proved to work very well at large 
scale, as long as the protein of interest survives the acidic conditions. TCA precipitation 
works good for flavodoxin'18'1 and the FMN-binding domain of cytochrome P450 
BM3[105], which can stand these extreme conditions very well. The acid ammonium 
sulfate precipitation method appeared to be especially useful for 'recalcitrant' 
flavoenzymes such as lipoamide dehydrogenase (LipDH) from pig heart'1231 and glucose 
oxidase from Aspergillus nigeA2*5\ although with both enzymes partial irreversible 
denaturation occurred, and variable amounts of reconstitutable apoprotein were obtained. 
Typical yields were in the 35 to 80 % range. Strittmatter showed that addition of a high 
concentration of KBr (1 M) to the acid ammonium sulfate solution weakens the 
electrostatic interactions between the flavoprotein and the flavin. This increased the 
apoprotein yield from 75 to 90 % in the case of cytochrome b5 reductase'2751, and from 
60 to 75 % in the case of oxynitrilase'2561. Further addition of charcoal, to adsorb the free 
flavin, resulted in an even more efficient removal of the prosthetic group'34'180'241]. 
Unlike flavodoxins'1821, many flavoproteins are not very stable at low pH. Therefore, 
a procedure of apoprotein preparation was developed based on dialysis at more 
physiological pH. Flavoproteins can be deflavinated using a high concentration of halide 
anions'163'214]. Equilibrium techniques such as dialysis and ultrafiltration'261 can be used 
successfully at physiological pH values for flavoenzymes, which bind the flavin 
prosthetic group rather weakly. D-amino acid oxidase'38' 163' 2291, cyclohexanone 
monooxygenase'2441, phenol hydroxylase'2111 and 2,4-dichlorophenol hydroxylase'2361 
apoprotein can be obtained by simple dialysis in the presence of KBr. KC1 has been used 
as well'2921, but it is a less effective salt because it is less chaotropic. 
Instead of time-consuming dialysis or ultrafiltration procedures, gel filtration 
methods are more efficient. Biogel P-6 and Sephadex G-25 have been applied 
successfully because with these resins the relatively small flavin molecules can be 
quantitatively separated from the apoprotein at relatively large scale'691. Care should be 
taken to stabilise the thus formed apoprotein, for instance by addition of stabilising 
factors to the washing buffer. Glucose oxidase apoprotein, for instance, is prepared by 
acidification of an enzyme solution to pH 1.7, followed by separation on a Sephadex G-
25column'199'241'2481. 
Another procedure of apoprotein preparation is to partially unfold the holoprotein 
with guamdinium hydrochloride'32' 2041 or urea'43' 306' 313], thus lowering the binding 
strength between protein and flavin. A disadvantage of this method is that one needs to 
find conditions in which the partially unfolded apoprotein is capable to refold. Circular 
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dichroism spectroscopy1156'205'303'305] and fluorescence spectroscopy[207,299'305] are useful 
here to probe the folding behaviour of the protein of interest. 
For many metalloflavoproteins, most of the conventional apoflavoprotein preparation 
procedures cause extensive denaturation. A likely explanation for this is that 
deflavination and reconstitution of flavoproteins is more difficult if the quaternary 
structure is more complex, i.e. when the protein contains more cofactors and/or subunits. 
The molybdenum-containing flavoprotein xanthine oxidase'1671 can be deflavinated by 
dialysis at physiological pH in the presence of 2 M CaCl2[136l The FAD released is 
hydrolysed to FMN by the high concentration of salt present. Other methods are based 
upon this technique, and include Ca^F^C^^ 1 0 1 or KI[124]. An interesting 
metalloflavoenzyme is the molybdo iron-sulfur flavoprotein carbon monoxide 
dehydrogenase from Oligotropha carboxidovorans, which X-ray structure was 
elucidated recently'59' 60l The recombinant flavoprotein was deflavinated on a gel 
filtration column, but the free apoflavoprotein did not bind FAD. However, when the 
apoflavoprotein was complexed with the iron-sulfur protein and molybdoprotein 
components, the flavin binding site is capable to integrate FAD[100]. 
Addition of a phosphodiesterase (i.e. Naja naja atra, snake venom) or phosphatase to 
dilute solutions of flavoprotein shifts the equilibrium to the apo form, because the free 
FAD or FMN is hydrolysed. The reaction is relatively fast, but not very useful at large 
scale. Moreover, extra care must be taken to remove the remaining cleavage enzyme[201l 
C. Chromatographic procedures 
For several flavoproteins, the conventional methods of apoprotein preparation are 
most satisfactory. A good example is the TCA precipitation procedure developed for 
flavodoxinsfl81l Multidimensional NMR studies have shown that the extreme conditions 
for apoflavodoxin preparation do not lead to any structural perturbation in the 
reconstituted holoprotein, compared to the native protein'3041. However, with many 
flavoproteins, and especially when large amounts of apoprotein are required, (affinity-
based) chromatographic procedures are the methods of choice. One of the main 
advantages of these methods is that on-column protein aggregation is unlikely to occur, 
since each molecule is at a relatively large distance from its neighbours. Particularly 
during partial unfolding, this helps stabilising the apoform of the protein, before flavin 
reconstitution. 
CI. Non-covalent binding 
Ion-Exchange Chromatography (IEC) 
Separation in ion-exchange chromatography depends upon the reversible adsorption 
of charged solute molecules to immobilised ion exchange groups of opposite charge. For 
successful on-column flavin removal, conditions are needed where the protein interacts 
with the ion-exchanger (low ionic strength) and not with the flavin (low pH). This 
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concept was first worked out for the riboflavin-binding proteins (RfBPs) from chicken 
egg white'14'75] and chicken egg yolk'1731. These proteins belong to a family of carrier 
proteins which are involved in vitamin delivery to the developing embryo'3201. The holo 
forms of the chicken RfBPs can be separated in the apo forms and free riboflavin by 
cation-exchange chromatography at pH 3.7. The apoprotein-riboflavin complex 
dissociates between pH 3.8 and 4.0'183l At pH 3.7, the neutral highly fluorescent 
riboflavin is released from the column whereas the apoprotein remains tightly bound. 
The apoprotein can subsequently be released from the column by raising the pH and 
ionic strength of the elution buffer to pH 4.1 and 0.5 M NaCl. 
Unlike most other flavoproteins, apo RfBP interacts strongly with a large number of 
flavin derivatives but not with FMN or FAD'141. The structure of RfBP is rather 
unusual'1921. Besides from an N-terminal ligand-binding domain that is strongly 
conditioned by nine disulfide cross-links, it contains a flexible phosphorylated motif 
with nine phosphoserines, which is essential for vitamin uptake'1861. The isoalloxazine 
ring of the tightly bound riboflavin molecule is stacked in between two tryptophans, 
explaining the strong fluorescence quenching observed upon flavin binding. 
The interaction between apo RfBP and riboflavin in the oxidised and two-electron 
reduced state has been addressed by reconstitution of the protein with 13C- and 15N-
enriched riboflavin derivatives'1961. Except from giving insight into the solvent 
accessibility and conformational properties of the protein-bound flavin, these studies 
revealed that in the reduced state, the pK^ of the Nl atom of the flavin is shifted by about 
0.8 pH unit to more alkaline pH values as compared to that of free reduced flavin. This 
shift to a pKa value of 7.45 is quite unusual, because in many flavoproteins, the Nl atom 
of the reduced flavin is negatively charged'39'200' 291l 
The effective binding of riboflavin to the apoform of RfBP has also received 
biotechnological attention. Apo RfBP was shown to scavenge riboflavin in model beer 
solutions, thereby inhibiting the light-induced formation of reactive oxygen species and 
sunstruck off-flavour'139'297]. 
Hydrophobic Interaction Chromatography (HIC) 
To circumvent severe protein loss using conventional techniques, a generally 
applicable immobilisation procedure was developed for the large scale preparation of 
apo flavoproteins using hydrophobic interaction chromatography'3001. This method 
makes use of the fact that many flavoproteins bind to phenyl agarose at neutral pH in the 
presence of 1 M ammonium sulfate. After immobilisation, the flavin can then be 
removed by the addition of high concentrations of KBr and/or lowering the pH of the 
elution buffer. The HIC method has been successfully applied for a number of 
flavoproteins'295'300], sometimes with slight modifications, to get optimal results'79' 143' 
257] 
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The HIC method for preparing apoflavoproteins works very well for prokaryotic and 
eukaryotic disulfide reductases, including LipDH, glutathione reductase, and mercuric 
reductase, and is preferred over classical methods'3001. For LipDH, it was shown that the 
kinetics of holoenzyme reconstitution are dependent on the source of enzyme'2951 and on 
the type of flavin'531. Initial FAD binding to the monomelic apoprotein results in 
regaining of DCPIP activity and quenching of tryptophan fluorescence. Then, 
dimerisation occurs as reflected by the regain of lipoamide activity, strongly increased 
FAD fluorescence and increased hyperchroism of the visible absorption spectrum'2951. 
For LipDH from A. vinelandii, the conformational stability of the monomelic apoprotein 
was compared with that of the dimeric holoenzyme'2991. Unfolding of the apoenzyme in 
GdnHCl follows a simple two-state mechanism and is fully reversible. However, the 
midpoint of unfolding of the monomelic apoprotein (Cm GdnHCl = 0.75 M) is much 
lower than that of the dimeric holoenzyme (Cm GdnHCl = 2.4 M). GdnHCl unfolding 
was also used to probe the conformational stability of A. vinelandii lipoamide 
dehydrogenase in the different redox states'2991. From this and additional mutagenesis 
studies it was inferred that overreduction by NADH promotes subunit dissociation and 
that the C-terminus of the protein plays an important role in dimer stabilisation'16'17' 176l 
Sometimes the apoprotein interacts very strongly with the HIC column material and 
apoprotein elution or on-column reconstitution can be difficult. In such case, the 
apoprotein may undergo irreversible conformational damage, e.g. by local unfolding or 
subunit dissociation. This was observed to some extent with the apoprotein of butyryl-
CoA dehydrogenase from Megaspheara elsdeniP°°\ which can not be reconstituted 
when bound to the column. By using high concentrations of ethylene glycol as eluent, 
stable apoprotein showing negligible residual activity could be isolated with 50-80 % 
yield. Spectral analysis of the apoprotein revealed that the coenzyme A persulfide ligand 
present in the native protein'3221 is removed during apoprotein preparation. At pH 7.0 and 
25 °C, the apoprotein is a mixture of dimers and tetramers, and reassociates to a native-
like tetrameric form in the presence of FAD. The reconstitution with FAD is relatively 
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Figure 2.2 Time-dependent reactivation of apo butyryl-CoA dehydrogenase with 
FAD, in the absence (•) and presence (A) of 1 mM CoASH, or in the presence of 0.5 
mM acetoacetyl-CoA (0), according to'3001. Note that the presence of 0.5 mM 
acetoacetyl-CoA results in about 65 % inhibition. 
Binding of CoA ligands stimulates tetramerisation of the reconstituted holoenzyme 
and improves protein stability. This is in agreement with the crystal structure of butyryl-
CoA dehydrogenase'1321 which shows that the CoA ligand binds in an extended 
conformation near the dimer-dimer interface. Fluorescence-polarisation experiments 
revealed that the reconstituted protein is somewhat less stable than the native 
holoprotein, and that FAD dissociates more easily'3001. In Figure 2.3, a schematic 
representation is given of the possible mechanisms of reconstitution of apo butyryl-CoA 
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Figure 2.3 Possible mechanisms for the reconstitution of apo butyryl-CoA 
dehydrogenase by FAD (F), and in the presence of coenzyme A (A). For the species 
between brackets, no experimental evidence is available (figure according to'3001). 
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Another protein that was successfully deflavinated by the HIC method is L-amino 
acid oxidase (LAAO) from the venom of Crotalus adamanteus, the eastern diamondback 
rattlesnake13181. This rattlesnake, which has a row of large dark diamonds with brown 
centres and cream borders down its back, feeds primarily on small mammals, from mice 
to rabbits. They locate their prey by odour, as well as by sensing the infrared waves 
emitted by warm-blooded prey[5' 47l LAAO is a dimeric glycoprotein, containing one 
FAD per monomer, that catalyses the oxidative deamination of L-amino acids. The 
deflavination method for LAAO[23?1 is similar to the original protocol developed for 
LipDH. Apo-LAAO remains bound to the HIC column, while the FAD cofactor is 
washed away in a buffer with 1.5 M ammonium sulfate. Apo-LAAO can be 
reconstituted with FAD on-column. However, the FAD-reconstituted LAAO is inactive, 
having a perturbed conformation of the flavin binding site. In the presence of 50 % 
glycerol the reconstituted LAAO becomes nearly completely active. It was suggested 
that repulsion of glycerol from hydrophobic surfaces of the protein and the simultaneous 
interaction with protein polar regions initiates the restoration of the internal protein 
hydrophobic core. Thus, glycerol can have a restorative effect on the proposed partially 
unfolded equilibrium intermediates, and acts as a molecular chaperone[237l This function 
of glycerol was first demonstrated for the pig kidney D-amino acid oxidase (DAAO) 
mutant H307L[189'317]. The replacement of His307 with leucine perturbs the active site 
conformation causing a dramatic loss of enzyme activity due to the weakening of the 
protein-flavin interaction. The negative effect of this mutation can be eliminated in the 
presence of glycerol, resulting in up to 50 % activity recovery and more than 16-fold 
increase of flavin affinity. From this it was concluded that glycerol assists in the 
rearrangement of the protein towards the holoprotein conformation, as well as in 
reducing the solvent accessibility of the protein hydrophobic core[238l 
Hydroxyapatite Chromatography (HAP) 
Hydroxyapatite, Ca(P04)3OH2, is a crystalline form of calcium phosphate which can 
be used for the separation and purification of proteins. This column material often 
separates proteins shown to be homogeneous by other chromatographic techniques. 
Ceramic hydroxyapatite is a recently developed, spherical, macroporous form of 
hydroxyapatite, which overcomes the flow limitations of the crystalline material and 
allows use in large-scale columns. It has a high protein-binding capacity and similar 
elution characteristics as crystalline hydroxyapatite. 
For preparation and reconstitution of apoflavoproteins, HAP has the advantage that 
high salt concentrations, which can stimulate apoprotein formation, are not necessarily a 
limitation. The interaction between the protein and HAP is primarily the result of non-
specific electrostatic interactions between the positively charged protein amino groups 
and the negatively charged column materia^981. The deflavination process is influenced 
by the charge distribution of the protein, as well as the kind of salt that is used as eluent. 
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The HAP method of apoflavoprotein preparation was used for a recombinant form of the 
flavin-binding subunit of the flavocytochrome p-cresol methylhydroxylase (PCMH) 
from Pseudomonas putida^ and for the His61Thr variant of vanillyl-alcohol oxidase 
(VAO) from Penicillium simplicissimum[85,286}. In native VAO, the 8a-methyl group of 
the FAD isoalloxazine ring is covalently bound to the N3 atom of His422t18, 175]. 
Structural and functional analysis of His422 and His61 variants have shown that His61 
activates the neighbouring His422 for covalent binding of FAD[84'851 (see Figure 2.4). In 
the His422Ala and His61Thr variants, the covalent His422-C8a-fiavin linkage is not 
formed but the mutant enzymes are still active and capable of binding FAD. 
Figure 2.4 Flavin binding in VAO. In native VAO, His61 (red) activates the 
neighbouring His422 (green) for covalent binding of the FAD (yellow) cofactor. The 
aromatic ring of the inhibitor isoeugenol (blue) is situated parallel to the flavin 
isoalloxazine ring. 
Binding the His61Thr variant to hydroxyapatite appeared to be a very gentle and 
efficient method of obtaining the VAO apoprotein. Upon washing with 200 mM 
phosphate buffer pH 7.2, the His61Thr protein remains tightly bound to the column, 
whereas the FAD is easily removed. This removal of FAD is superior to other methods. 
For instance, when the His61Thr holoenzyme is eluted on a Biogel P6 gel filtration 
column in 50 mM phosphate buffer pH 7.0 in the absence or presence of high salt, 
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almost no flavin is released. Another advantage of the HAP method for protein 
defiavination is that the His61Thr VAO apoprotein can be eluted in concentrated form 
by simply washing the column with 600 mM potassium phosphate pH 7.2. 
While native VAO forms primarily octameric assemblies of 507 kDa, the apo 
His61Thr variant exists in solution as a dimer of 126 kDa (see Figure 2.5). Binding of 
FAD or ADP to the dimeric apoenzyme induces octamerisation. In contrast, incubation 
with riboflavin or FMN does not stimulate octamer assembly, suggesting that upon FAD 
binding, small conformational changes in the ADP-binding pocket of the dimeric VAO 
mutant are transmitted to the protein surface, thus promoting oligomerisation[286l 
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Figure 2.5 Nano-electrospray mass spectra of native VAO (a) and mutant apo 
His61Thr VAO (b), with a representation of the corresponding quaternary structures 
(figure according to[286]). 
Fluorescence titration studies showed that the dissociation constant of the apoprotein-
FAD complex in the His61Thr variant is about 0.2 p.M. In the His422Ala variant, the 
FAD is much more strongly bound[84]. This might explain why the HAP method 
described above for the His61Thr variant does not work for the His422Ala variant of 
VAO. Thus, for on-column releasing the FAD cofactor in mutant His422Ala, conditions 
need to be found that weaken the protein-flavin interaction, while the protein remains 
bound to the HAP support. As noted above, an interesting approach here would be to 
introduce other type of salts in the washing buffer. 
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Dye-Affinity Chromatography (DAC) 
Polyaromatic dyes can bind to proteins that use a cofactor with a nucleotide 
moiety'551. Cibacron Blue has a strong affinity for the Rossmann Pap dinucleotide 
binding fold'156'243], and many flavoproteins possess such a fold, either for binding the 
ADP part of FAD and/or NAD(P)'32'1. This feature can be used to separate apo and holo 
flavoproteins'2891. Such a separation was performed with Cibacron Blue Sepharose for 
fiavocytochrome b2[230], and for DAAO[146]. 
Red-A agarose, another polyaromatic dye-containing material, has been used for the 
deflavination of p-hydroxybenzoate hydroxylase (PHBH) from Pseudomonas 
fluorescens[22i\ Under low ionic strength conditions, the red dye of the column binds to 
the enzyme, displacing the FAD. The column is then eluted with high-ionic strength 
buffer containing the artificial flavin 6-azido-FAD, which binds to the protein and 
displaces the dye. The 6-azido-FAD cofactor can be covalently linked to the protein by 
irradiation. Enzyme that has not been photolabeled is separated from the covalently 
photolabeled enzyme by applying the reaction mixture to a Red-A column again. At low 
ionic strength, the nonlabeled enzyme binds to the column material, whereas the 
photolabeled enzyme passes directly through the column191,2221. 
C2. Covalent binding 
When partial unfolding of the holoprotein is required to weaken the protein-flavin 
interaction, the above mentioned chromatographic methods for protein deflavination 
may not work properly because of the presence of high concentrations of unfolding 
agents. Therefore, we introduced the concept of covalent enzyme immobilisation for 
improving the yield and quality of the apoprotein'2011 
For PHBH, the prototype of the family of single-component flavoprotein 
hydroxylases'681, it was shown that large amounts of highly reconstitutable apoprotein 
can be prepared by covalently binding the enzyme to thiol (DTNB) agarose'20'1. PHBH 
forms a dimer in solution, and contains 5 sulfhydryl groups per monomer'2031. However, 
Cysll6 is the only solvent exposed thiol group, accessible to N-ethylmaleimide and 
DTNB'3011. Using this property, it is possible to bind the enzyme covalently to the thiol-
agarose column. Oxidation'2981 or mutation'731 of Cysll6 does not influence catalysis but 
prohibits binding of the protein to the DTNB column. In Figure 2.6, the PHBH dimer is 
shown, as well as the solvent accessibility of the Cysll6 sulfur atom. After coupling to 
the column material, the FAD can be released from the protein with urea and KBr. The 
resulting column bound apoprotein is released after reaction with DTT. On-column 
reconstitution of the apoprotein with an artificial or isotopically labelled flavin analog is 
possible as well. Upon reaction with DTT, the colour of the column turns from pale 
yellow to dark red due to the formation of the 2-nitro-5-thiobenzoate anion. After 
regeneration with DTNB, which allows to determine the capacity of protein binding'151' 
2011
, the column is slightly yellow again. 
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The mildness of the thiol agarose method for apoflavoprotein preparation was 
confirmed by the high resolution crystal structure of PHBH reconstituted with arabino-
FAD[296l Nevertheless, the thiol affinity chromatography method requires the presence 
of a freely available thiol group at the protein surface, making the method not generally 
applicable12981. Although the introduction by mutagenesis of a surface accessible cysteine 
is in principle possible with every flavoprotein, knowing beforehand that this cysteine is 
indeed solvent exposed and will not interfere with catalysis might sometimes be a long 
shot. 
Figure 2.6 3D-strucrure of PHBH. PHBH is a dimer, and contains 1 FAD cofactor 
(green) per monomer. In the dimer, the only solvent-exposed cysteine is Cysll6. In the 
right panel, all amino acid residues within a distance of 10 A to the Cysl 16 sulfur atom 
(yellow) are shown. The solvent accessibility of the sulfur atom is indicated with yellow 
dots, and Cysl 16 is drawn with Vanderwaals-radii. 
Furthermore, the newly introduced cysteine should not interact intra- or 
intermolecularly with other cysteines. This can easily be tested with the DTNB 
reaction'671. Due to its high standard oxidation-reduction potential, DTNB reacts with 
protein thiols by an exchange reaction to form a mixed disulfide of the protein and 1 
mole 2-nitro-5-thiobenzoate per mole of protein sulfhydryl groups. The formed 
nitromercaptobenzoate anion has an intense yellow colour (with £4i2=13,600 IVT'cm"1), 
and solvent-exposed protein thiols give complete colour development within 2 
minutes[104). For preparation of apo PHBH, the original DTNB-agarose has recently been 
replaced by commercially available thiopropyl sepharose[216~2,8]. 
Immobilised Metal-Affinity Chromatography (IMAC) 
The introduction of recombinant DNA techniques has opened the possibility to add 
an affinity tag to proteins, facilitating protein purification. These affinity tags can be 
used to covalently bind a protein to a column. In IMAC, certain solvent exposed amino 
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acids (e.g. histidine, cysteine and tryptophan) form complexes with the chelated 
transition metals at neutral pH. Introduction of a polyhistidine tag to either the N-
terminal or C-terminal end of the protein of interest facilitates a strong binding to the 
column bound metal ion. This strong binding is only disrupted by high concentrations of 
imidazole, an acidic pH or chelating agents such as EDTA. Thus, when a flavoprotein is 
bound to such a column, in principle rather harsh washing steps can be used to 
successfully remove the flavin prosthetic group. After on-column deflavination, the 
apoprotein or reconstituted protein can be eluted from the affinity matrix with a high 
concentration of imidazole. 
The IMAC method of apoflavoprotein preparation was developed for the flavin-
containing PAS domain of NifL, a redox-sensing protein from A. vinelandiP^. The PAS 
domain is purified as described in chapter 3[114l Deflavination was achieved by 
exploiting the available N-terminal His-tag (chapter 4,[113]). Usually, 10 mg of purified 
protein in 50 mM Tris-HCl, pH 7.5 containing 0.3 M NaCl, was applied onto a 1 ml 
nickel-nitrilotriacetic acid (Ni-NTA) superflow column, preequilibrated in the same 
buffer. Protein-bound FAD was efficiently removed by washing the column with 10 
volumes of starting buffer, containing 2 M KBr and 2 M urea, resulting in a column-
bound apo-form of the protein. The apoprotein could be removed from the column with 
250 mM imidazole, but precipitated within 12 hours after release from the column. 
Therefore, on-column reconstitution was achieved by circulating a 10 mM solution of 
2,4a-13C2-FAD or 2,4a-13C2-FMN overnight (4 °C) at 0.2 ml/min in 50 mM Tris-HCl, pH 
7.5 containing 0.3 M NaCl (see Figure 4.1). 
The reconstituted PAS domain containing a new flavin cofactor was eluted from the 
column with 2 column volumes 50 mM Tris-HCl buffer pH 7.5, containing 0.3 M NaCl 
and 250 mM imidazole. Reconstitution of the flavoprotein is 100 % efficient, as shown 
by NMR and UV-VIS absorption spectroscopy (see Figure 4.2 and Figure 4.4). 
In the case of NifL, the IMAC method can best be used to prepare reconstituted 
protein instead of apoprotein, due to the instability of the apoprotein formed. Due to the 
immobilisation of the apoprotein during the process of de- and reflavination, no severe 
protein loss is observed. The reconstituted protein, containing isotopically labelled FAD 
or FMN, is used to study the PAS core, the direct environment of the flavin prosthetic 
group[1131. Although the NifL PAS domain normally binds FAD, the His-tag 
reconstitution method unambiguously showed that this protein also tightly interacts with 
FMN. 13C and 31P NMR experiments confirmed that there is no significant difference in 
the active site between the FAD- or the FMN- reconstituted protein in either the reduced 
or oxidised state (see chapter 4;[112]). 
The use of IMAC for the preparation and reconstitution of His-tagged apo 
flavoproteins by immobilisation on a Ni-NTA column, might become a general method 
since His-tag incorporation in recombinant proteins is every-day work. 
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CONCLUSIONS AND FUTURE PERSPECTIVES 
Since the pioneering work of Theorell[288], many methods have been developed for 
the (large scale) preparation and reconstitution of apoflavoproteins. Conventional 
precipitation methods, such as the acid ammonium sulfate procedure, are rapid but the 
yield and reconstitutability of apoprotein may vary dramatically. The more recently 
developed chromatographic procedures have the advantage that the apoprotein is 
stabilised by immobilisation, and that large amounts of apo- or reconstituted 
flavoproteins can be obtained. 
His-tagged flavoproteins can be purified, deflavinated and reconstituted on the same 
column. Therefore, the use of IMAC for flavoprotein deflavination and reconstitution 
should be further exploited. An interesting possibility to facilitate flavin release with 
such a column is to deflavinate the protein in its reduced state. In the reduced form, 
flavin binding sometimes is less tight than in the oxidised form'160' 271l The introduction 
of a solvent exposed cysteine residue is another engineering strategy that allows the 
covalent binding of a flavoprotein to a solid support. Although not always 
straightforward, this method produces high quality apoflavoproteins in very good 
yield[20,l 
Site-directed mutagenesis can also be used to change the strength of the flavin-
apoprotein interaction. With such approach, it is important that the amino acid 
replacements (or deletions) do not result in dramatic changes in protein stability and/or 
enzyme catalysis. The feasibility of this approach for the preparation of apoflavoproteins 
is demonstrated by the above mentioned studies on AIF, LipDH, NQR, MTHFR, and 
VAO and is further illustrated by the following example: By rational design, a surface 
loop of 14 amino acid residues was removed from Rhodotorula gracilis DAAO[228l This 
shifted the protein from the dimeric into the monomelic state. In the monomelic state, 
the FAD interacts more weakly with the protein, because the cofactor is now solvent 
accessible. The apoprotein of the DAAO mutant was then obtained by dialysis in the 
presence of a chaotropic agent[38]. 
Sometimes, site-directed mutagenesis is needed to improve the flavin-apoprotein 
interaction. With L-aspartate oxidase, a FAD-dependent enzyme involved in the 
microbial biosynthesis of NAD+, the protein could only be crystallised in the 
apoform[177]. All attempts to crystallise the wild-type enzyme in the holo form were 
unsuccessful. However, the Arg386Leu mutant, in which an active site arginine is 
replaced, turned out to be amenable to crystallisation and structure elucidation in the 
active FAD-bound state[28]. 
In the near future, other recombinant-based methods such as the construction of 
fusion proteins will undoubtedly emerge for flavoprotein deflavination and 
reconstitution. These procedures will be also valuable for the preparation of apo forms of 
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A general procedure for the purification of histidine-tagged proteins has been 
developed using immobilised metal-ion affinity chromatography. This two-step 
purification method can be used for proteins containing a hexahistidine tag and a 
thrombin cleavage site, yielding high amounts of purified protein. The advantage of this 
method is that thrombin is used instead of imidazole, in the final purification step. 
Imidazole can influence NMR experiments, competition studies or crystallographic 
trials, and the presence of imidazole often results in protein aggregates. Removal of the 
His-tag results in a form of the protein of interest in which no additional tags are present, 
resembling the native form of the protein, with only 3 additional amino acids at the N-
terminal side. Our method is compared with a more conventional method for the 
purification of the Azotobacter vinelandii NifL PAS domain, overexpressed in E. coli. It 
also proves to be successful for three different His-tagged proteins, the Klebsiella 
pneumoniae NtrC protein, and the A. vinelandii NifA and NifL proteins, and therefore it 
is a general method for the purification of His-tagged proteins. 
INTRODUCTION 
In 1975, Porath and co-workers[232] first described immobilised metal-ion affinity 
chromatography (IMAC). Metal-ions bound to an agarose matrix have the tendency to 
form complexes with proteins that have surface-exposed imidazole and thiol groups such 
as histidines, tryptophans or cysteines. This observation made it possible to easily purify 
proteins from complex mixtures by attaching a polyhistidine-tag to the N- or C- terminus 
of proteins (for an overview read[64'233'2781). In principle a single step IMAC purification 
procedure is used, in which the polyhistidine-tagged protein is washed from the matrix 
with imidazole17'51'141'150'252] and the imidazole is subsequently removed by dialysis. In 
some cases, however, even extensive dialysis cannot remove all imidazole bound to the 
protein. For certain experiments, such as NMR measurements, crystallisation trials or 
interaction studies, it is necessary to fully remove imidazole. Moreover, the presence of 
imidazole can result in aggregation of the protein[259l 
The introduction of an endopeptidase cleavage site adjacent to the histidine-tag 
facilitates removal of the tag. A thrombin cleavage site is frequently used'263'272'312] since 
thrombin recognises a highly specific cleavage sequence1411. 
Here we present a general applicable method, in which the protein of interest is 
cleaved from the His-tag directly on the column and no extensive dialysis is necessary. 
This two-step purification method for His-tagged proteins results in pure protein in the 
absence of the tag, and without requirement for imidazole in the final elution step. 
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EXPERIMENTAL PROCEDURES 
Materials 
All chemicals used were commercially available and at least of reagent grade. Unless 
stated otherwise double distilled deionised water was used (at least 18 megaOhm/cm) 
using the NANOpure system from SYBRON Barnstead, Boston, USA. For 
chromatography, the following buffers were made and filter-sterilised (0.22 urn GVWP 
Millipore filters): Buffer A: 50 mM Tris - 300 mM NaCl - 20 mM imidazole (Merck), 
pH 7.5; buffer B: 50 mM Tris - 300 mM NaCl - 250 mM imidazole, pH 7.5; buffer C: 50 
mM Tris - 300 mM NaCl, pH 7.5; buffer D: 50 mM Tris - 300 mM NaCl, 2.5 mM 
CaCl2, pH 7.5. 
Protein expression 
Overproduction of the Klebsiella pneumoniae NtrC protein and the Azotobacter 
vinelandii NifA, NifL, and the NifL PAS domain proteins was achieved using the T7 
expression system (for an overview on the different proteins and their function read[57]). 
DNA fragments derived either by PCR amplification or restriction digestion were cloned 
into the expression vector pET28b (Novagen) and expressed in the BL21 (DE3) pLysS 
E. coli strain. Plasmid pMB737 contains the full-length nifA gene derived from 
pDB737[6], plasmid pDW78 the full-length ntrC gene from pNH31[58], and plasmid 
pTJ45 the full-length nifL gene derived from pPW53[6]. Plasmid pKH416, which 
overexpresses the amino-terminal PAS domain of NifL from amino acid Ml to HI40, 
was derived by PCR amplification of pPW53. All plasmids contained an N-terminal His-
tag with an adjacent thrombin cleavage site and in all cases coding sequences were 
flanked by an Ndel site at the start codon and a BamHl site following the stop codon. 
E. coli cells were first grown on LB plates supplemented with 50 ng/ml kanamycin 
(Sigma). Single colonies were transferred to 5 ml prewarmed LB medium containing 50 
ug/ml kanamycin. After overnight growth this culture was transferred to a 2-litre flask 
containing 500 ml prewarmed medium. Cells were grown with vigorous shaking (300 
rpm) to a density of Agoo = 0.4 (corresponding to approx. 0.5*109 E. coli cells per ml) 
before protein expression was induced with 1 mM IPTG (Gibco). Cells were harvested 
by centrifugation at 4 °C for 20 minutes at 10,000g after reaching a cell density of A ^ = 
0.6-0.8. The cells were resuspended in 40 ml cold buffer A, and passed 3 times through a 
French Press. This suspension was centrifuged for 20 minutes at 20,000g. The cell pellet 
was resuspended with buffer A and centrifuged again, reducing the protein loss in this 
step. The supernatant was passed through a 0.45 um non-sterile FP 30 filter (Schleicher 
& Schuell) to avoid clogging of protein aggregates or cell debris on the Ni-NTA column. 
Purification Procedure 
All experiments were performed in a cold room (4 °C). The Ni-NTA Superflow 
(Qiagen, Valencia, USA) column material is comprised of Ni2+-nitrilotriacetic acid 
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coupled to Superflow resin (Sterogene Bioseparations, Inc.). The TALON (Clontech, 
CA, USA) column material consists of a special polydentate metal chelator, which 
tightly retains cobalt, and uses Sepharose CL-6B (Pharmacia-LKB Biotechnology, 
Uppsala, Sweden) as a durable matrix. The Ni-NTA column can be regenerated, while 
the TALON column cannot, according to the manufacturers protocols. For this reason 
the Ni-NTA column was always used as the first column, because after several 
purifications a brownish smear was observed on top of the column. Though both IMAC 
columns use the same principle, there may be differences in their specific affinity. IMAC 
columns were prepared by pouring 25 ml resin into a XK-16/20 (Ni-NTA) or a XK-
26/20 (TALON) glass tube column (Pharmacia) containing water, and settling of the gel 
bed was accelerated by connecting the column outlet to a pump running with a flow 
speed of 0.5 ml/min. The column was connected to a Gradifrac system with an in-line 
A28o-detector (Pharmacia) connected to a recorder, and equilibrated with at least 10 
column volumes of buffer A. At all times the salt concentration was kept at 300 mM to 
avoid non-specific hydrophobic or ionic interactions. 
A) Imidazole-basedpurification method 
This method was used to purify the Azotobacter vinelandii NifL PAS domain 
protein. After French Press disruption the protein solution was loaded onto the Ni-NTA 
column at a flow-speed of 1 ml/min. Weakly bound proteins were washed from the resin 
with buffer A. The recombinant histidine-tagged protein was eluted by increasing the 
imidazole concentration from 20 mM (buffer A) to 250 mM (buffer B) in 1 column 
volume. Eluted fractions were analysed by SDS-PAGE and fractions containing the 
tagged protein were pooled, diluted to 20 mM imidazole with buffer C and further 
purified using the TALON column. Then the protein was stripped from the TALON 
column using buffer B, resulting in a pure protein solution, containing a high 
concentration of imidazole. To fully remove imidazole it is necessary to extensively 
dialyse this protein solution. However, precipitation was observed upon dialysis (10 kDa 
membranes), independent of buffer conditions which resulted in loss of protein (Table 
3.1). Even if the protein solution was first diluted to a final imidazole concentration of 
about 50 mM precipitation still occurred. Although changing buffer conditions using the 
Amicon system (with YM-10 filter) is faster than dialysis, the protein also aggregated 
under these conditions (see Table 3.1). Removal of imidazole by using a 60 cm length 
desalting column (Bio-Gel P-6 Desalting Gel from Biorad) resulted in loss of protein 
(Table 3.1). Protein recovered after the second Amicon step (2.7 mg) was freeze dried 
and subsequently dissolved in 500 ul 20 % D20 solution with a final buffer 
concentration of 20 mM potassium phosphate pH 7.5; 50 mM KC1. NMR-spectroscopy 
showed that imidazole was still present in this protein solution, with an estimated 
concentration of about 50 uM resulting in two large proton peaks at 7.6 and 7.0 ppm. 
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Purification started with approximately one litre E. coli culture; cells were broken using a French Press. 
1
 The imidazole based purification method resulted in histidine-tagged protein. 
2
 The thrombin based purification method resulted in protein with no histidine-tag present. 
3
 Volumes and protein amounts were determined after each purification step. 
B) Thrombin-basedpurification method 
This method was developed because the imidazole-based purification method 
resulted in loss of protein due to the efforts necessary to fully remove imidazole. It uses 
on-column cleavage of the His-tag with thrombin. After French Press disruption (see 
Table 3.2) the protein solution was loaded on the Ni-NTA column. Following elution 
with imidazole all fractions containing tagged protein were pooled, diluted with buffer C 
to a final concentration of 20 mM imidazole and loaded on the TALON column (at a 
flow speed of 0.5 ml/min this took approximately 8 hours). After stabilisation of the A2go 
baseline the column was washed with at least 10 column volumes buffer D to remove 
imidazole. A catalytic amount of 100 NIH units thrombin (Sigma) was dissolved in 30 
ml buffer D, and this solution was circulated over the column at low speed (0.1 ml/min 
with a Pharmacia P-50 pump) by connecting the column outlet to the inlet. A Pharmacia 
UV-1 detector was used to monitor the A28o baseline and thus the cleavage process. After 
two to four days, dependent on the total amount of protein loaded on the column, this 
baseline stabilised and the cleaved protein was collected by washing the column with 
buffer D. After dialysing three times against 5 litre 5 mM ammonium bicarbonate, pH 
7.5 the amount of pure protein was determined (Table 3.2). To fully remove the His-tag 
still bound to the column at least 10 column volumes buffer B was used to clean the 
column before further use. 
SDS-PAGE 
Electrophoresis was performed using tricine as a trailing ion, according to the 
modified method[250] of Laemmlitl40]. The discontinuous gels consisted of a 4 % T, 3 % 
C stacking gel and a 16.5 % T, 3 % C separating gel for the NifL PAS domain or a 10 % 
T, 3 % C separating gel for the NifL, NifA, and NtrC proteins which were run on a 
vertical electrophoresis unit (SE 250 Mighty Small II, Pharmacia). T denotes the total 
percentage concentration of both monomers (acrylamide and bisacrylamide), and C the 
percentage concentration of the crosslinker relative to the total concentration T. Protein 
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bands were detected by staining with Serva Blue G. The low molecular weight markers 
were from Pharmacia. 
Table 3.2 Total protein yields in 
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5 4 . 2 
6 0 . 7 
39 .2 
4 8 . 4 
T a l o n 
(mg) 
4 7 . 3 
5 2 . 5 
2 8 . 5 
3 9 . 6 
MALDI mass-spectrometric analysis 
Matrix-assisted laser desorption/ionisation time of flight (MALDI-TOF) mass 
analysis was carried out on a PerSeptive Biosystems Voyager DE RP Biospectrometry 
Workstation. Matrix solutions were prepared by dissolving in a 1 ml mixture of 
acetonitrile:water 20 mg of either sinapinic acid (Aldrich) (1:2) or a-cyano-4-
hydroxycinnamic acid (Aldrich) (1:1) containing 1 % TFA. For analysis 1 ul matrix 
solution was mixed with 1 ul protein solution and applied to a 100-well gold-coated 
plate. Dilution series (1:10 to 1:1000) of protein in matrix solution were pipetted on the 
plate as well. Samples were allowed to dry in a gentle air stream for at least 1 hour. For 
measurement of protein masses above 5 kDa, sinapinic acid was used as matrix, and 
measurements were performed in linear mode. a-Cyano-4-hydroxycinnamic acid was 
used as a matrix for masses ranging from 500 Da to approximately 5 kDa and the 
detector was set in reflective mode. The mass spectrometer was operated in the positive-
ion mode with a delayed extraction time of 500 ns. Ions were accelerated to an energy of 
25 kV before entering the TOF mass spectrometer. To obtain optimised spectra the 
minimum laser power possible was used, and 30-100 spectra were accumulated for each 
run. The mass spectrometer was calibrated externally with a mixture of 8 proteins 
ranging from 1 kDa to 66 kDa, prepared as described above. 
Protein Quantification 
Both the NifL protein and its PAS domain contain a non-covalently bound FAD 
cofactor that remains tightly bound during purification. NifL is a tetramer in solution 
with an average FAD:protein tetramer ratio of 3:l[116l The NifL PAS domain also is a 
tetramer in solution (according to analytical gel filtration runs with a Superdex 200 HR-
10/30 column connected to an AKTAexplorer; data not shown) with an average 
FAD:protein tetramer ratio of 2:1. This was measured by comparing protein 
concentrations determined at 450 nm using an eFAD=H300 M^cm"1'3191 and determined 
as described by Bradford^311 using Bradford Reagent (Sigma) with bovine serum 
Albumin (Boehringer) as a standard. NtrC and NifA do not contain FAD and therefore 
the protein concentration was determined using the Bradford method. 
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RESULTS AND DISCUSSION 
Large-scale Production and Purification of the Polyhistidine-taggedproteins 
Small-scale experiments indicated a higher protein-yield if the cells were first grown 
to a density of A^o = 0.4 before IPTG induction was started. After French Press 
disruption approximately 80 % of the His-tagged proteins were in the soluble fraction, as 
estimated by SDS-PAGE. Although protein solutions were carefully filtered before 
loading on the Ni-NTA IMAC column, a brownish band was observed on top of this 
column after several runs. This band could be removed by washing and regenerating the 
column material according to the manufacturer's protocol. Together with the His-tagged 
protein, typically 3 to 4 E. coli proteins were co-purified in small amounts (Figure 3.1, 
lane 6). Although binding of His-tagged protein is based on the same principle, the use 
of two different IMAC columns eliminates copurification, which occurs if one uses just 
one column[259]. Because dialysis of fractions containing the His-tagged protein often 
resulted in precipitation of the protein due to the high imidazole concentration, this step 
was omitted. We decided therefore to reduce the imidazole concentration of all protein-
containing fractions by adding buffer C to a final concentration of 20 mM. This protein 
solution, containing 4 to 5 different proteins, was then loaded overnight on the TALON 
column. At a loading speed of 0.5 ml/min all His-tagged proteins bound to the IMAC 
columns, as no His-tagged protein was detected in the flow-through (Figure 3.1, lane 7). 
The column was then extensively washed with buffer D to remove imidazole. The 
masses of the thrombin-cleaved proteins were checked using the mass spectrometer 
(Table 3.3). After thrombin was added to start cleavage, the A28o base-line increased 
indicating that protein was cleaved from the histidine-tag. This resulted in a 100 % pure 
protein with no imidazole present (Table 3.2 and Figure 3.1, lane 9). The masses of the 
proteins were compared with the theoretical thrombin-cleaved masses, and cleavage 
always occurred at the thrombin cleavage site (Table 3.3). 
Protein Quantification 
Imidazole has a dramatic influence on the accuracy of protein concentration 
determination using the Bradford method. We observed a two-fold increase in 
absorbance when comparing dilution series of bovine serum albumin in the absence and 
presence of 500 mM imidazole. However, in the absence of imidazole (as determined by 
NMR spectroscopy), the amount of purified protein can be measured using the Bradford 
method. This method gave equivalent values to those found when using the eFAD at 450 
nm or when using the estimated £28o[95]-
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Jt£H -
•i Q Lane 1 - molecular weight marker. 
2- E. coli cells prior to IPTG 
induction. 
3- cells 2 hours after IPTG 
addition. 
4- cells 3 hours after IPTG 
addition. 
5- supernatant from French Press 
disruption. 
6- after Ni-NTA column. 
7- TALON column flow-through 
during loading. 
8- TALON column eluant after 
thrombin digestion and cleaning the 
column with buffer B, about 10 
times concentrated. 
9- NifL PAS domain released from 
the TALON column by on-column 
cleavage. 
10- molecular weight marker. 
Figure 3.1 SDS-PAGE of the different steps in the on-column cleavage purification 
method using the NifL PAS domain. 
In Table 3.2 a purification scheme is shown for all 4 proteins. Following French 
Press disruption protein was determined using the Bradford method, and after the Ni-
NTA IMAC column purification using the eFAD (NifL, NifL PAS) or the Bradford 
method (NifA, NtrC). The A2go absorbance was measured continuously during the on-
column enzymatic cleavage of these proteins using the TALON IMAC column. After 2 
to 4 days no further increase in absorbance was observed, resulting in 100 % pure 
protein (Figure 3.1, lane 9). Addition of another 100 NIH units thrombin did not result in 
an increase of the absorbance, indicating that all proteins with a solvent exposed 
cleavage site were cleaved from the column. 

















 The displayed values are the average [M+H]+ masses calculated with the EXPASY Proteomics tools 
(http://www.expasy.ch/tools/peptide-mass.html) after cleavage at the predicted thrombin cleavage site. 
2
 The masses determined with MALDI-TOF MS are of the thrombin-cleaved protein domains, and 
represent the average [M+H]+ mass. 
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CONCLUSION 
The high specificity of IMAC towards His-tagged proteins and the high specificity of 
thrombin for its cleavage site can be combined in a purification method for His-tagged 
proteins. Previous methods for histidine-tag removal have required purification and 
extensive dialysis1224' 261l The method described here works very efficiently with the 4 
His-tagged proteins tested in this study. The high selectivity of IMAC column material 
towards histidine-tags, combined with on-column removal of the tag with thrombin 
results in a two-step purification with high overall yield. If the TALON column is not 
washed extensively with buffer D before starting on-column thrombin cleavage, high 
concentrations of imidazole remain bound to the protein after repeated dialysis, as 
detected by NMR spectrometry. The presence of imidazole can be problematic for NMR 
measurements, or for long time storage12591. In the final purification step, about 15 % 
protein is lost during the cleavage procedure. This is partially due to the removal of 
copurified E. coli proteins, but, after cleaning the TALON column with buffer B both the 
His-tag and non-cleaved protein are visible on SDS-PAGE (Figure 3.1, lane 8). This 
suggests that thrombin cleavage is not 100 % complete and not all protein is released 
from the column. The protein that is released from the column, however, is 100 % His-
tag free (lane 9). 
A problem that could occur is clogging of the TALON column due to circulating a 
highly concentrated protein solution. This can be avoided by removing the cleaved 
protein after 2 days, and starting on-column cleavage again by addition of a new 
catalytic amount of thrombin. Because the on-column thrombin cleavage takes 
approximately 2 to 4 days at 4 °C, this method might not be applicable for less stable 
proteins, although higher concentrations of thrombin can be used to accelerate the 
cleavage process. Thrombin is expected to be several fold more active at 20 °C than at 4 
°C, so we believe that the whole cleavage experiment could be performed in 12 - 24 
hours. In our case 4 °C was used, because the NifL protein is known to be less stable at 
room temperatures. In our protocol, thrombin is not removed from the purified protein. 
In our experience, no further protein cleavage is observed on SDS-PAGE even after 3 
months at 4 °C (0.1 % NaN3). For NMR measurements this very low concentration of 
thrombin is not a problem, as long as no further cleavage occurs, but also because it is 
not visible in the NMR spectra. If necessary, further purification can be achieved by 
adding agarose beads coated with anti-thrombin (Antithrombin III from Sigma) to the 
final protein solution. Alternatively, the thrombin cleavage capture kit (Novagen, 
Calbiochem) can be used. The thrombin can then be removed by centrifugation. 
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The NifL PAS domain from Azotobacter vinelandii is a flavoprotein with FAD as the 
prosthetic group. Here we describe a novel immobilisation procedure for the large-scale 
preparation of apo NifL PAS domain and its efficient reconstitution with either 2,4a-13C-
FAD or 2,4a-13C-FMN. In this procedure, the His-tagged holoprotein is bound to an 
immobilised metal affinity column and the flavin is released by washing the column with 
buffer containing 2 M KBr and 2 M urea. The apoprotein is reconstituted on-column 
with the (artificial) flavin cofactor, and then eluted with buffer containing 250 raM 
imidazole. Alternatively, the immobilised apoprotein can be released from the column 
matrix before reconstitution. The His-tag based immobilisation method of preparing 
reconstituted (or apo) NifL PAS domain protein has the advantage that it combines a 
protein affinity chromatography technique with limited protein loss, resulting in a high 
protein yield with extremely efficient flavin reconstitution. This on-column 
reconstitution method can also be used in cases where the apoprotein is unstable. 
Therefore, it may develop as a universal method for replacement of flavin or other 
cofactors. 
INTRODUCTION 
The reversible dissociation of flavoproteins into its constituents, apoprotein and 
flavin prosthetic group, has received much attention1'19' 143' 202l Generation of a stable 
soluble form of the apoprotein is of great interest as it allows the reconstitution of the 
holoprotein with either artificial'94, 161- 326], enzymatically modified'2961 or isotopically 
enriched flavin analogues'79' 201- 245]. Conventional methods of apoprotein preparation 
include acid ammonium sulfate precipitation'2751, dialysis in the presence of chaotropic 
salts'1631 or treatment with unfolding agents'32'197]. These methods can lead to significant 
irreversible protein denaturation and are often not suited for large-scale applications. 
Therefore, we introduced the concept of reversible protein immobilisation for improving 
the yield and reconstitutability of the apoprotein'2011. 
For /7-hydroxybenzoate hydroxylase (PHBH) from Pseudomonas fluorescens it was 
shown that large amounts of highly reconstitutable apoprotein can be prepared by 
covalently binding the enzyme to thiol agarose'2011. The suitability of this mild procedure 
was confirmed by the high resolution crystal structure of PHBH reconstituted with 
arabino-FAD'2%1. However, the thiol affinity chromatography method requires the 
presence of a freely available thiol group at the protein surface, making the method not 
generally applicable'2981. Therefore, another immobilisation procedure was developed for 
the large-scale preparation of apo flavoproteins using hydrophobic interaction 
chromatography (HIC)'3001. 
This method makes use of the fact that many flavoproteins bind to phenyl agarose at 
neutral pH in the presence of 1 M ammonium sulfate. After immobilisation, the flavin 
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can be released by the addition of a high concentration of KBr and/or lowering the pH of 
the elution buffer. The HIC method has been successfully applied for a number of 
flavoproteins'237'257'295'3001, sometimes with slight modifications to get optimal results'79' 
1431
. A disadvantage of the HIC method is that with certain flavoproteins, the apoprotein 
is more hydrophobic than the holoprotein and is not easily removed from the column. In 
such case, the apoprotein may undergo conformational damage (e.g. subunit 
dissociation), leading to loss of enzyme activity'237,3001. Because not all flavoproteins do 
bind to a hydrophobic matrix, we sought for an alternative method for the large-scale 
preparation of apo flavoproteins. Here we describe a method, using immobilised metal 
affinity chromatography (IMAC). This IMAC method was developed for the FAD-
containing PAS domain of NifL. 
PAS domains are important signaling modules that monitor changes in light, redox 
potential, oxygen, small ligands, and overall energy level of a cell'3321. NifL, a redox-
sensing protein from A. vinelandif51\ is a member of this family. The N-terminal PAS 
domain serves as the flavin redox-sensing domain distinct from the C-terminal nitrogen-
responsive and nucleotide-binding domain. The NifL PAS domain (140 amino acids), to 
which an N-terminal 6xHis-tag and a thrombin cleavage site have been added'2651, has 
been overexpressed in E. coli. In contrast to previous work'114], and due to an improved 
purification method, the PAS domain purifies as a tetramer with 4 FAD molecules per 
tetramer. In the rhombohedral (R32) crystal form this domain contains 1 monomer per 
asymmetric unit'111'. Recently, a new structure with a PAS domain fold has been 
released'491. This domain from the phototropin module of Adiantum phy3 contains FMN 
as the cofactor. Because phy3 and the NifL PAS domain share an identical fold, it was of 
interest to study by 13C NMR the interaction of the NifL PAS domain with FMN, as well 
as with its native cofactor FAD. 
MATERIALS AND METHODS 
Protein purification 
The NifL PAS domain, including a 6xHis-tag and thrombin cleavage site at the N-
terminus, was obtained by overexpression of plasmid pKH-416 in the E. coli host strain 
BL21 (DE3) pLysS. The expression vector was pET28b (Novagen). The PAS domain 
was purified as described in'"41. 
Synthesis of 2,4a-'3C-FMN and 2,4a-'3C-FAD 
Barbituric acid was synthesised'1061 from 13C-labeled urea and diethyl malonate-1,3-
13C2 resulting in a yield of 89 %. This barbituric acid was refluxed for 5 hours with 3,4-
dimethyl-(6-phenylazo)-ribitylaniline, resulting in riboflavin'290'3101. 
For synthesis of 5'-FMN, the riboflavin was phosphorylated with phosphorous 
oxychloride'2581. The resulting crude FMN was purified on a 310 x 25 mm Lichroprep 
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RP18 column with a flow rate of 6 ml/min in 10 % methanol, 90 % 0.1 M NH4HC03 in 
water[213'. After freeze-drying, salt was removed by redissolving the FMN in water and 
reinjecting it on the same column. For this step, the eluent used is 50 % methanol in 
water. The pure 5'-FMN obtained was freeze-dried and stored at -20 °C before further 
use. 
FAD was prepared enzymatically from riboflavin with FAD synthetase11581. The 
resulting crude FAD was purified on a 20 x 2 cm Lichroprep CI8 column at a flow rate 
of 4 ml/min with a gradient from 0 to 25 % methanol in water. The resulting 2,4a-13C-
FAD was freeze-dried and stored at -20 °C before further use. 
250 mM 
Imidazole I 250 mM Imidazole 1 
Figure 4.1 Schematic representation of the preparation and reconstitution of His-
tagged apo flavoproteins by immobilisation on a Ni-NTA column. 
Immobilized metal affinity chromatography 
A schematic representation of the on-column reconstitution of flavoproteins is 
presented in Figure 4.1. 15 mg of purified PAS domain in 50 mM Tris-HCl buffer pH 
7.5 containing 0.3 M NaCl, was applied onto a 1 ml preequilibrated Ni-NTA superflow 
(Qiagen) column (Figure 4.1 A). After loading the protein solution at a flow rate of 0.2 
ml/min, the column outlet was connected with the pump inlet, creating a loop to ensure 
maximal binding of protein to the column (Figure 4. IB). After overnight circulation (0.2 
ml/min) at 4 °C in the dark, the loop was disconnected. Protein-bound FAD was then 
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removed by washing the column with 10 volumes of starting buffer, containing 2M KBr 
and 2 M urea, resulting in a column-bound apo-form of the protein (Figure 4.1C). The 
column was washed with 10 column volumes of a 50 mM Tris-HCl buffer pH 7.5 
containing 0.3 M NaCl. On-column reconstitution of the apo form was done by 
circulating a 10 mM solution of 2,4a-13C-FAD or 2,4a-13C-FMN overnight (4 °C) at 0.2 
ml/min (Figure 4.ID) in 50 mM Tris-HCl buffer pH 7.5 containing 0.3 M NaCl. Excess 
cofactor was then removed by washing with 50 mM Tris-HCl pH 7.5, containing 0.3 M 
NaCl. The reconstituted apo PAS domain containing a new flavin cofactor was eluted 
from the column with 2 column volumes 50 mM Tris-HCl buffer pH 7.5, containing 0.3 
M NaCl and 0.25 M imidazole (Figure 4.IE) and concentrated to 10 mg/ml by 
ultrafiltration (Millipore Ultrafree 5K centrifugal filter). 
300 350 400 450 500 
Wavelength (nm) 
550 600 
Figure 4.2 Absorption spectra of the NifL PAS domain. The untreated holo protein (line 
a) shows similar flavin absorption characteristics as protein on-column reconstituted 
with 13C-FAD (b) and 13C-FMN (c). Part of the apoprotein (d) formed aggregates 
immediately after removal from the IMAC column, but the remaining protein-containing 
solution clearly does not contain FAD or FMN. For clarity, the absorption value at 600 
nm was set to zero for (d) and shifted upwards 0.05 a.u. for (c), 0.1 a.u. for (b), and 0.15 
a.u. for (a), respectively. 
For preparing the apo form of the PAS domain the apoprotein was eluted from the 
column after flavin removal, with 2 volumes of 50 mM Tris-HCl buffer pH 7.5, 
containing 0.3 M NaCl and 0.25 M imidazole (Figure 4.IF), and concentrated to 
approximately 3 mg/ml by ultrafiltration (Millipore Ultrafree 5K centrifugal filter). The 





Protein concentrations were determined using the Bradford assay (Sigma). 
Calibration was done with known BSA concentrations (Pierce) using disposable 
cuvettes. Absorbance spectra were recorded at a Hewlett Packard Chemstation 8433 UV-
visible diode-array spectrometer using Hellma 1cm light path quarts cuvettes. 
Circular dichroism spectra (195-260 nm) were recorded with a J-715 Jasco 
Spectropolarimeter with Starna 1 mm light path quarts cuvettes. All CD measurements 
were performed at 20 °C with a scanning speed of 20 nm/min and 8 times averaging. 
Protein concentrations (in 50 mM KC1 and 50 mM potassium phosphate buffer pH 7.4) 
were adjusted to an optical density of 0.2 at 450 nm. The ellipticity at 250 nm was 
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Figure 4.3 Circular dichroism spectra of the NifL PAS domain. The untreated holo 
protein (line a) and the 13C-FAD (b) and 13C-FMN (c) reconstituted proteins show 
similar characteristics, indicating similar secondary structure elements. All proteins were 
diluted in 50 mM potassium phosphate pH 7.4, 50 mM KC1 to an A450 = 0.2 (lines (a) 
and (b) were shifted upwards for clarity). 
For 13C-NMR experiments, 0.7 mM protein was dissolved in 50 mM Tris-HCl, 50 
mM K.C1, pH 7.4, containing 10 % D20. Measurements were performed at 15 °C using a 
9.4 T Avance 400 NMR spectrometer. Proton decoupling was achieved with a GARP 
sequence and spectra were recorded as described before'307'310]. For measuring protein 
samples in the reduced state, the Wilmad 5 mm NMR tubes were filled with 0.50 ml 
sample, and de-aerated by flushing with argon for 10 minutes. Subsequently, a 10-fold 
excess of buffered dithionite over flavin concentration was added. 
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Figure 4.4 13C-NMR spectra of (a) reduced 2,4a-13C2-FAD containing NifL PAS 
domain, and (b) oxidised 2,4a-13C2-FMN containing NifL PAS domain. 
RESULTS AND DISCUSSION 
Apoprotein preparation 
FAD release from the NifL PAS domain with 2 M KBr and 2 M urea (Figure 4.1) is 
very efficient and can easily be monitored visually. Instead of on-column reconstitution, 
it is possible to elute the apo PAS domain from the IMAC column with two column 
volumes of a buffer containing 250 mM imidazole (Figure 4. IF). Unfortunately, the free 
apo-protein of the PAS domain formed aggregates immediately after removal from the 
IMAC column and is not stable in solution. 
Reconstitution of apoflavoprotein 
Because the apo-PAS domain is not stable in solution, we explored the possibilities 
of on-column replacement of the FAD cofactor with an alternative cofactor. The strong 
interaction between the N-terminal His-tag of the protein and the Ni-NTA matrix turned 
out to facilitate this replacement. Reconstitution of the column-bound apoprotein with 
13C-FAD or 13C-FMN is highly effective with a 100 % cofactor replacement yield. 
However, due to the extensive washing steps about 15 % of the loaded protein is lost. 
Properties of the reconstituted NifL PAS domain 
Figure 4.2 shows that replacement of the native FAD cofactor with 13C-FMN or 13C-
FAD does not change the characteristic flavin absorption spectrum of the PAS domain. 
The raise in baseline for the apoprotein at lower wavelengths is caused by small 
aggregates formed. From the spectrum can be concluded that the sample indeed is flavin-
free, and thus represents the apo-form of the protein. Figure 4.3 shows the far-UV CD 
spectra of the native, and the reconstituted PAS domain protein. Unfortunately, the 
aggregation of the apo-protein prevented reliable CD measurements. However, after on-
column reconstitution the PAS domain does fold nicely, as shown by the identical CD-
spectra of the holo- and FAD-reconstituted form, and with marginally different 
characteristics of the FMN-reconstituted form. Analytical gel filtration experiments 
using a Superdex 200 30/10 column revealed that the tetrameric state of the NifL PAS 
domain does not change after exchange of the FAD for the FMN cofactor. Moreover, 
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comparison of the protein concentration with the flavin concentration showed that the 
cofactor to protein ratio is not changed. 
To further demonstrate the powerfulness of the His-tag based flavin exchange 
technique, the 13C-NMR spectrum of the 2,4a-13C-FAD reconstituted NifL PAS domain 
protein in the reduced state is shown in Figure 4.4. Two peaks arising from the 13C 
labeled FAD are visible, at 156.2 (C2) ppm and 99.8 (C4a) ppm, respectively. For the 
reduced 2,4a-13C-FMN reconstituted protein the C2 and C4a atoms have the same 13C 
chemical shift (156.2 ppm and 99.8 ppm), indicating that there is no difference in the 
chemical environment of the isoalloxazine moiety of reduced FAD- or FMN-
reconstituted PAS domain. Moreover, the 13C-NMR linewidths of the bound FAD and of 
the bound FMN are nicely Lorentzian shaped, indicating that the cofactor is tightly 
bound with absence of conformational averaging. The 13C chemical shift of the C2 and 
C4a values are in close agreement with the corresponding values'791 ofp-hydroxybenzoate 
hydroxylase'3111. This indicates that in the reduced state the NifL PAS domain protein 
has a negatively charged FAD cofactor. In the oxidised state the C2 and C4a 13C 
resonances of FAD- and FMN- labeled PAS domain are 157.4 ppm, 134.7 ppm (FAD) 
and 157.2 ppm, 134.7 ppm (FMN), indicating again that there is no difference in the 
chemical environment of the two flavin cofactors. The 13C linewidths indicate that in the 
oxidised state conformational averaging occurs. 
CONCLUSIONS 
This paper clearly shows that the FAD cofactor of the His-tagged PAS domain of 
NifL can be replaced on-column by IMAC. The polyhistidine tag allows a strong 
interaction between the protein and the IMAC column material. The efficient removal of 
FAD, and the subsequent on-column reconstitution, is fast and can be used on a 
preparative scale. 
Since the apo-PAS domain is not very stable in solution, the on-column 
reconstitution is the method of choice to prevent precipitation of this apo-protein. On-
column reconstitution of the flavin cofactor with 13C-FAD or 13C-FMN does not change 
the oligomerisation state of the NifL PAS domain, and neither does it change the 
chemical environment of the flavin. Thus, this method is especially useful when the 
apoform of the protein is not stable in solution due to aggregation and precipitation, 
since it stabilises the apoform of the protein during the reconstitution procedure. 
In principle, His-tags can be introduced in every recombinant protein. Any His-
tagged protein with a non-covalently bound cofactor can be immobilised on an IMAC 
column, opening possibilities to exchange the cofactor in high yield. This cofactor does 
not necessarily need to be a flavin. Therefore, on-column replacement of protein-bound 
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The A. vinelandii NifL protein is a redox-sensing flavoprotein, which inhibits the 
activity of the nitrogen-specific transcriptional activator NifA. The N-terminal PAS-
domain has been overexpressed in E. coli and crystallised by the hanging-drop vapour-
diffusion method. The crystal belongs to the rhombohedral spacegroup i?32, with unit 
cell parameters a = b = 64.9 A, c = 157.4 A and has one molecule in the asymmetric 
unit. Native data were collected to 3.0 A on the BW7B synchrotron beamline at the 
EMBL Hamburg Outstation. Initial attempts to crystallise Seleno-Methionine labeled 
protein failed, but structure elucidation using molecular replacement strategies seems to 
be successful. In this chapter preliminary data of the partially elucidated structure are 
reported (Jason Key et al. unpublished results). 
INTRODUCTION 
PAS-domains are ubiquitous motifs present in bacteria, archaea and eucarya'3321. 
Unlike most other sensory domains, PAS-domains are located in the cytosol[28?1 and 
include histidine'11 and serine/threonine kinases'2311, chemoreceptors and photoreceptors 
for taxis and tropism'2691, circadian clock proteins'1281, voltage-activated ion channels'3161, 
cyclic nucleotide phosphodiesterases'2661, as well as regulators of responses to 
hypoxia'1211 and embryological development of the central nervous system'2101. The 
specificity of a PAS-domain for detecting input signals is partly determined by the 
cofactor associated with the PAS-domain. Five PAS-domain protein structures are 
known; the bacterial blue-light photoreceptor PYP'27'92], the heme-binding domain of the 
rhizobial oxygen sensor FixL'97'191], the N-terminal domain of the human ether-a-go-go-
related potassium channel HERG'1981, the FMN containing phototropin module of 
Adiantum PHY3[49], and the human PAS kinase'41. To date, no crystal structures of PAS-
domains are known which contain FAD as cofactor. The A. vinelandii NifL protein is an 
FAD-containing redox-sensing protein which inhibits the activity of the nitrogen-
specific transcriptional activator NifA, in response to molecular oxygen and fixed 
nitrogen'571. The N-terminal PAS-domain serves as the flavin redox-sensing domain'2651. 
In order to understand the different mechanisms by which PAS-domains work, detailed 
information about their cofactor binding regions is required. 
PROTEIN PRODUCTION AND CRYSTALLISATION 
The amino-terminal PAS-domain of A. vinelandii NifL, containing an N-terminal 
histidine tag with an adjacent thrombin cleavage site, was overexpressed in the E. coli 
strain BL21 (DE3) pLysS and purified as described previously11141. For the production of 
selenomethionyl-labeled protein E. coli strain BL21 (DE3) pLysS was first grown on LB 
plates supplemented with 50 |^ g/ml kanamycin (Sigma). Single colonies were transferred 
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to 5 ml prewarmed LB medium (37 °C) containing 50 ug/ml kanamycin. After overnight 
growth 500 ul medium was transferred to a 2-litre flask containing 500 ml prewarmed 
non-sterile M9 medium[246]. This M9 minimal medium was supplemented with 50 mg/1 
of all 20 aminoacids (in which methionine was replaced with selenomethionine), 100 
mg/1 kanamycin and 0.6 % w/v glucose. Cells were grown with vigorous shaking (300 
rpm) for 15 hours, before protein expression was induced with 1 mM IPTG. After 6 
hours the cells were harvested and the protein purified as described before'1141, resulting 
in 9 mg pure protein from a 4 litre culture. Prior to crystallisation the freeze-dried protein 
was dissolved in double-distilled deionised water and the protein concentration was 
determined using Bradford's assay. Initial crystallisation trials were carried out using the 
hanging-drop vapour-diffusion method on Linbro plates. A hanging drop (2 \i\) prepared 
by mixing 1:1 each of the protein solution and the reservoir solution was placed on a 
siliconised cover slip over 0.6 ml of the reservoir solution. Initial screening for 
crystallisation conditions was performed with Screen I[1201 and II (Hampton Research), 
and with Wizard I and II (Emerald Biostructures) screening solutions using protein 
concentrations of 6 to 8 mg/ml, at 293 K. Initial crystal growth was observed with 2.0 M 
ammonium sulfate as salt, and 5 % v/v isopropanol as precipitant. Because crystals were 
observed in conjunction with amorphous precipitate, subsequent crystallisation 
experiments were carried out to try to optimise the conditions, including pH, salt and 
precipitant concentration, as well as protein concentration. Protein crystals always 
formed after initial light precipitate (Figure 5.1), and seems to be insensitive to the pH 
used. 
.,«A>5i-^--^j 
Figure 5.1 Yellow crystals of NifL PAS-domain protein, containing the FAD 
cofactor, grown by the hanging drop method. The average dimensions of these crystals 
were 0.1x0.1x0.1 mm. 
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The best conditions were found to be 1.8 M ammonium sulfate and 4.5 % 
isopropanol. Small crystals of the selenomethionine containing protein formed after 12 
days under the same conditions, except for the addition of 10 mM p-mercaptoethanol to 
the well-solution, but they dissolved again after a further five days. No new crystal 
growth was observed subsequently. 
X-RAY ANALYSIS 
Diffraction data to 3 A resolution were collected at 100K with synchrotron radiation 
(X = 0.8424 A) at the BW7B beamline at the EMBL-Hamburg outstation using a 
MAR345 image plate detector. A total of 110 images were recorded with an oscillation 
angle of 0.5° and an exposure time of 4 minutes per image. The crystal-to-detector 
distance was set to 300 mm. Prior to data collection, a crystal was equilibrated for a few 
seconds in a cryoprotectant solution prepared by mixing 1:1 well-solution and 50 % v/v 
glycerol, then directly mounted in a CryoLoop (Hampton Research) and flash-cooled in 
the cold nitrogen stream. The intensity data were processed and scaled with the HKL 
package[220l A high rejection probability was used in SCALEPACK (0.099) during 
scaling because of the high completeness and redundancy of the data. The crystals are 
rhombohedral with a=64.9 A, c=157.4 A. With one molecule in the asymmetric unit the 
Matthews coefficient is 2.01[178l Data collection details are given in Table I, and a 
typical crystal is shown in Figure 5.1. 






U n i t - c e l l parameters (A) 
Total observat ions 
Independent r e f l e c t i o n s 
Completeness ( %) 
I/O (I) 
M o s a i c i t y (°) 
EMBL Hamburq, BW7B 
0.8424 
100 
40 - 3 .0 [ 3 . 1 1 - 3 .0 ] 
J?32 
a = 6 4 . 8 9 , c = 157 .39 
28038 
2667 
9 7 . 5 [98 .5 ] 
1 7 . 7 [3 .3 ] 
5 . 1 [38 .8] 
0 .82 
Values in square brackets are for the highest resolution shell 
MASS-SPECTROMETRY STUDIES 
Prior to crystallisation the mass of the purified PAS domain protein was checked 
with MALDI-TOF to verify the correctness of the thrombin cleavage. The determined 
mass (15897.5 Da) was in excellent agreement with the expected theoretical mass 
(15898 Da). Protein crystals were washed in well-solution and dissolved in the MALDI-
TOF matrix solution. Mass spectra were recorded, with a low signal to noise ratio. The 
estimated mass was approximately 16000 ± 150 Da, indicating that the initial crystals 
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contained thrombin-cleaved protein. Selenomethionyl labelled protein contains two 
selenium atoms (15991 Da), as expected (theoretical mass 15991.3 Da) from the number 
of methionines in the protein sequence. The selenium incorporation was over 95 % 
efficient, estimated from the peak-heights. 
MOLECULAR REPLACEMENT 
A number of search models for the NifL PAS domain were constructed based upon 
the known structures of PHY3, PYP, FixL, and HERG. Of these, the most successful 
models by far were constructed using the FMN containing structure PHY3. The search 
model contained the side chains of 15 residues that are strictly conserved between NifL 
and PHY3. All other amino acid residues, except glycine, were changed to alanines. 
Thus, a search for the 140 NifL PAS residues was performed with a search model 
containing 100 residues, of which 85 were glycine or alanine. 
The program EPMR[1341 is a program that finds crystallographic molecular 
replacement solutions using stochastic search models. The program simultaneously 
optimises the three rotational and three positional parameters for a search model. EPMR 
was used to search for the molecular replacement solution using several resolution 
ranges between 25 and 3 A. The range between 10 to 4 A yielded the best results. Due to 
inadequacy of the used search models, all solutions produced by EPMR had low 
correlation coefficients and high R-factors. In order to find the correct solution, several 
thousand runs were performed with each search model, while writing out each solution 
for each run. The resulting solutions with the most promising correlation coefficients and 
R-factors were examined for realistic packing interactions in the cell unit. Most 
candidate solutions violated packing considerations, produced overlapping symmetry 
mates, and were therefore incorrect. One solution consistently appeared with both the 
highest correlation coefficient and lowest R-factor, and showed a unit cell with 
reasonable packing interactions (Figure 5.2a). The correlation coefficient of this 
solution, containing only 15 residues with side chain atoms, was 37 % with an initial R-
factor of 55.5 %. This solution occurred in less than 0.8 % of the EPMR runs. After 
adding the co-ordinates of FMN from PHY3 to the search model, the correlation 
coefficient increased to 41.5 % with an R-factor of 54.8 %. With this addition of FMN, 
the solution occurred in approximately 2 % of the EPMR runs. 
OMIT MAPS 
In order to determine if the molecular replacement solution was correct, 2F0-FC maps 
were calculated from the original search model which lacked most side chain residues 
and the FAD cofactor. The FAD omit maps revealed density for the flavin isoalloxazine 
ring as well as the phosphate tail of FAD (Figure 5.2b). In addition, density is visible for 
63 
Chapter 5 
the majority of the peptide backbone of the model, and a number of side chains. 
Although the initial R-factor of this solution was 55 %, it was possible to add a number 
of side chains to the model, and build part of the N- and C-terminal residues. Upon doing 
so, the free R-factor dropped to 48 %. Density modification by solvent flipping was 
useful in building some portions of the model, and currently the R-factor is 42 %. To 
date, of the 143 amino acid residues, 117 backbone atoms and about 75 side chain 
residues are added to the search model (in total 755 atoms). This means that about half 
of the residues in the search model lack their side chain. 
Figure 5.2 (A) Crystal packing interactions of the EPMR solution for the NifL PAS 
domain in the R32 unit cell. (B) The 2F0-FC map reveals electron density for the FAD 
flavin ring. The map is contoured at l o (cyan) and 2o (blue). 
DISCUSSION 
It is questionable as whether this model can be refined to a satisfactory R-factor. Due 
to the low resolution and the incompleteness of the model, there is some difficulty using 
software which relies on molecular dynamics (simulated annealing, conjugate-gradient 
minimisation) to refine the model. As the model is continuously improved, this should 
become less of a problem. That means that at this stage considerable manual refinement 
has to be done. Significant sections of the model are incorrect, most obviously the first 
turn of the N-terminus. 
Given the high completeness and Ilo{I) in the last resolution shell (Table 5,1), it 
seems likely that higher resolution data could be obtained from these crystals. To date, 
no crystals with diffraction beyond 3 A have been obtained. Growing high quality 
crystals may be a challenging task, being a key to a successful structure determination 
and to sound biological interpretation. 
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The A. vinelandii NifL protein is a redox-sensing flavoprotein which inhibits the 
activity of the nitrogen-specific transcriptional activator NifA. The N-terminal PAS 
domain of NifL is a sensory domain, with 4 FAD molecules per tetramer. This domain 
was examined by synchrotron small-angle X-ray solution scattering. The experimental 
scattering data leads to a global fold of the tetrameric domain at low-resolution. Fitting a 
model of the PAS domain to this dummy atom model leads to a better understanding of 
the dimerisation / tetramerization interface. The resulting low resolution structure of the 
NifL PAS domain shows a well developed, anisometric shape of four monomers 
attached to each other. This tetrameric form is in agreement with analytical gel filtration 
experiments which also conform a homo-tetrameric state of this domain. 
INTRODUCTION 
In A. vinelandii the redox-sensitive, flavin-containing sensor protein NifL regulates 
NifA, an enhancer binding protein that controls the expression of nitrogen fixation genes 
in response to the concentration of fixed nitrogen and extracellular oxygen[57,116l Signal 
transduction is mediated via protein - protein interactions'193'194' 254l NifA is active in the 
absence of NifL, both in vivo and in vitro. The NifA protein activates transcription at the 
oN-dependent promoters for nitrogen fixation genes. NifL negatively controls the 
transcriptional activation by NifA, by acting as a specific anti-activator in response to the 
environmental signals. The signals that lead to this inhibitory effect of NifL are diverse. 
It is activated in response to the level of fixed nitrogen, as well as the redox state'152,153' 
240] 
The NifL protein is comprised of two domains; the N-terminal PAS domain and the 
C-terminal ADP-binding domain, which are linked by a Q-linker'25l Q-linkers are 
relatively short, hydrophilic sequences, rich in Arg, Gin, Glu, Pro and Ser. The Q-linker 
serves a simple but essential role in tethering the structurally distinct, but interacting 
domains of regulatory proteins'3241. The C-terminal domain of NifL shows homology to 
the histidine protein kinase transmitter domains'251. The presence of ADP increases the 
inhibitory activity of NifL, binding to the C-terminal domain of NifL, independent of the 
redox state'74' 26Sl The NifL redox sensing function is well understood'116'155'254], and is 
located in the N-terminal PAS domain. This domain of the A. vinelandii NifL protein 
senses the redox status, and is a member of the PAS domain superfamily'3321. These PAS 
domains are important protein domains that can monitor changes in oxygen (FixL), light 
(e.g. phytochromes), and redox state (Aer, NifL, ArcB) of a cell. These motifs have been 
found in bacteria, eucarya and archaea. They are, unless most of the other sensory 
domains, located in the cytoplasm'287'. 
NifL is a homotetramer in solution in oxidised form, requiring the PAS domain 
region to retain this tetrameric state'116'265]. Also NifA is a homotetramer in solution. In 
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the presence of MgADP, NifL-NifA complexes, which were either isolated from cell 
extracts or formed in vitro, sieved with an apparent molecular mass of approximately 
500 kDa on a Superose 12 column. This would be consistent with stoichiometry of a 
tetramer of NifL bound to a tetramer of NifA[1941. The FAD:protein tetramer ratio is 
believed to be 4:1 both for NifL as for the PAS domain. This is observed when using a 
fast purification protocol, or after reconstitution of apo-NifL or apo-PAS domain with 
FAD[113], although in the past this number used to vary between 3:1 and 2:lt114'I16]. 
EXPERIMENTAL PROCEDURES 
Sample preparation 
The amino-terminal PAS domain of A. vinelandii NifL, containing an N-terminal 
histidine tag with an adjacent thrombin cleavage site, was overexpressed in the E. coli 
strain BL21 (DE3) pLysS and purified as described previously^141. This PAS domain 
(amino acid residue Ml-HI40, monomeric mass 17.8 kDa) with N-terminal extension 
(MGSSHHHHHHSSGLVPRGSH) was concentrated to 15 mg/ml and buffer-exchanged 
into 50 mM Tris-HCl, 300 mM NaCl. pH 7.5, at 4 °C. The protein was centrifuged at 
high speed for 20 minutes, to avoid large protein aggregates in the sample, before 
scattering experiments. Protein concentration was determined as described by 
Bradford'311 using Bradford reagent (Sigma) with bovine serum albumin (Boehringer) as 
a standard. 
Analytical gel filtration 
The NifL protein from A vinelandii is a tetramer in solution1"6'2651. To find out if the 
same applies for the PAS domain analytical gel filtration experiments were run on an 
Akta Explorer (Pharmacia Biotech). 50 ul of the His-tagged PAS domain protein (2 
mg/ml), in 100 mM potassium phosphate buffer, 150 mM KC1 (pH 7.0) was loaded on a 
Superdex 200 10/30 column at a flow speed of 0.5 ml/min. Calibration of this column 
was performed with blue dextran, alcohol dehydrogenase, ovalbumin, myoglobin, and 
cytochrome C. The retention time of the PAS domain sample corresponds to a tetrameric 
form of the protein. 
MALDI mass-spectrometric analysis 
Matrix-assisted laser desorption/ionisation - time of flight (MALDI-TOF) mass 
analysis was carried out on a PerSeptive Biosystems Voyager DE RP Biospectrometry 
Workstation. The matrix solutions used to prepare the protein samples were prepared, 
and the MALDI-TOF operated, as described in[I14]. The mass spectrometer was 
calibrated externally, with a mixture of 8 proteins in the range from 1 to 66 kDa. In 
Figure 6.1 the MALDI-TOF MS spectrum is shown of this protein. The NifL PAS 
domain protein, including the N-terminal His-tag, has a experimental average mass of 
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17652 Da ± 25 Da (peak A). This is in close agreement with the theoretical mass of the 
NifL PAS domain, without the N-terminal methionine (17648 Da). It is often observed 
that this N-terminal Methionine is missing12541. An additional peak at 18433 Da is 
observed (peak B). The difference between both peaks is 780 Da, caused by the addition 
of one FAD cofactor (783.5 Da). 
A 17652.7 
10000 14000 18000 22000 26000 30000 
Mass (m/z) 
Figure 6.1 MALDI-TOF MS spectrum of the His-tagged NifL PAS domain. Peak A 
(17652 Da) corresponds to the average mass of one monomer, while the mass-increase 
of 780 Da is caused by FAD (peak B). 
Modelling of the NifL PAS domain 
The partially elucidated X-ray structure listed in Chapter 5 is used to create a model 
of the monomeric PAS domain. In this X-ray structure, all amino acid side-chain 
residues that have not been elucidated (yet) are substituted for alanines. This protein 
sequence is shown in Figure 6.2. 
NifL 3D Structure ALPAXARCA VEHAPAMAA TDLAAAILAA NRAFATAAGY 
NifL model MGSSHHHHHH SSGLVPgfsH MTPANPTLSN EPQAPHAESD ELLPEIFgQT VIHAEISISI SDiKJNILYA MftFRTITGY 
Thrombin 
90 100 110 120 130 140 150 160 
.... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | 
NifL 3D structure GSEEALGAAA SILANGAAPA AVAQALAGAA AAAKPWSGAL ANAAAAATLY IAELTVAPVL AAAGATAYYA GAHRAA 
NifL model GJEEVLG.KKE SIISHSTTRR LYYfiSLWgRL ftQKKEHSSVL. VHRRKDKffiX 1AELTVAPVL NE&G.EUHL SNmPTSELH 
Figure 6.2 Sequence alignment of the NifL PAS domain model with the partially 
elucidated X-ray structure. All amino acid residues that are identical in both sequences 
are bold and underlined, and the thrombin cleavage site is indicated. 
There are two reasons why there is no template available for the N-terminal 41 amino 
acid residues of the model sequence. First, the protein used for SAXS experiments had 
an N-terminal His-tag and thrombin cleavage site. This site is removed in the protein 
crystallography experiments, resulting in a difference in sequence length of 17 amino 
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acid residues between the protein used for x-ray crystallography and the protein used for 
the SAXS measurements. Second, the N-terminal region of the protein sequence of the 
protein used in the x-ray studies (24 residues in total) has still not been elucidated in the 
partially elucidated X-ray structure, probably due to large mobility of this area. The 
protein sequence was modelled to the partially elucidated NifL PAS structure (Figure 
6.2) using MODELLER version 6.2'2l From 100 models created, the 9 best models were 
used to create low resolution SAXS solution models. These 9 models were fitted against 
the experimental SAXS data. This resulted in one tetrameric model with the best fit. This 
model was energy-minimised using the Amber forcefield in Insight II. The number of 
iterations was set to 1000, and the pH was 7.0. After energy minimisation, a monomelic 
model was fitted again against the experimental SAXS data, resulting in a new 
tetrameric model with a lower %2- After another optimisation-round, the final x2 was 
0.90. The resulting best fit is shown in Figure 6.3. 
Scattering experiments and data treatment 
The synchrotron radiation X-ray scattering data were collected using standard 
procedures on the double focusing monochromator-mirror camera X33[29'30' 135] at the 
European Molecular Biology Laboratory (EMBL) Hamburg Outstation on the storage 
ring DORIS III of the Deutsches Elektronen Synchrotron (DESY) using multiwire 
proportional chambers with delay line readout'891. Samples with protein solutions at 
concentrations between 5 and 18 mg/ml were analysed. The scattering curves were 
recorded at a wavelength X = 0.15 nm for a detector-sample distance of 1.7 m covering 
the momentum transfer range 0.15 < s < 2.3 nm"1 (s = 4;rsin0/X, where 20 is the 
scattering angle). Fifteen successive frames of 60 seconds each were recorded for each 
sample. The data were normalised to the intensity of the incident beam, and corrected for 
the detector response. The scattering of the buffer was subtracted, and the difference 
curves were scaled for protein concentration and extrapolated to infinite dilution 
following standard procedures'761 using the data reduction and processing program 
SAPOKO'2821. The molecular masses (MM) of the solutes were calculated by 
comparison with the forward scattering from reference solutions of bovine serum 
albumin (MM = 66 kDa). The maximum dimensions of the particles, Dmax, were 
estimated from the experimental data using the orthogonal expansion program 
ORTOGNOM[280]. The forward scattering 1(0), and the radii of gyration Rg were 
evaluated using the Guinier approximation'1021 assuming that at very small angles 
(s<1.3/Rg) the intensity is represented by 
i(S)=i(oys2R*/3 
These parameters were also computed from the entire scattering patterns using the 
indirect Fourier transform program GNOM'279' 283l This program also provides the 
distance distribution function, p(r), of the particles. 
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Shape determination /Structure modelling 
By comparison of the extrapolated forward scattering 1(0) with that of a reference 
solution of bovine serum albumin, the molecular masses of the solutes were estimated. 
Prior to the shape analysis, undesirable contributions from the scattering due to the 
internal particle structure at higher scattering angles that become significant above 
approximately s = 2.0 nm"1 were removed by subtracting a constant from the 
experimental data. The Porod volume Vp of the PAS domain was calculated from the 
processed scattering curves Ip(s) as 




where the computation of the integral in the denominator was performed as described'761. 
This procedure ensures that the intensity decays as s"4 following Porod's law[234] for 
homogeneous particles and yields an approximation of the "shape scattering" curve (i.e. 
scattering due to the excluded volume of the homogeneous particle with a constant 
density). The shape scattering curves in the ranges up to smax = 2.0 nm"1 were used to 
compute the excluded volumes V of the hydrated particles and for the ab initio shape 
determination. The outer portions of the curves, dominated by the scattering from the 
internal structure, were discarded in the further analysis. 
The low resolution model of the NifL PAS domain was built from the experimental 
data using the DAMMIN program. This program uses a single phase dummy atom 
model for the ab initio shape determination by simulated annealing'2811. A sphere of 
diameter D , ^ is filled by densely packed small spheres (or dummy atoms) of radius r0 
« Dmax- The scattering intensity I(s) of a given dummy atom model (or DAM) is 
calculated by a global summation over all dummy atoms (M » 1) using spherical 
harmonics expansion, to represent partial amplitudes. The scattering intensity from the 
DAM is computed using 
I(s) = 2x2YY}Alm{s)\2 
1=0 m=-l 
with the following partial amplitudes, 
Alm(s) = i-'j2^XjJ!(srjW+M) 
where the sum runs over the dummy atoms. The spherical Bessel function is denoted by 
ji(x), and rj and COJ are the particle atoms polar co-ordinates. 
Finding a DAM configuration corresponding by minimising the discrepancy between 
experimental and DAM calculated scattering curves is an ab initio reconstitution. Each 
bead belongs either to the protein (index = 1) or to the solvent (index = 0), and the shape 
is thus described by a binary string of length M. Starting from a random string, simulated 
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annealing[133] is employed to find a compact configuration of the beads, minimising the 
discrepancy % between the experimental IexP(s) and the calculated Icaic(s) curves: 





experimental error at the momentum transfer Sj. The X-ray scattering curves at higher 
angles contain significant contribution from the internal particle structure which must be 
removed prior to the shape analysis. For this, a constant is given by the slope on an s4I(s) 
vs. s4 plot, is subtracted from the experimental data to ensure that the intensity would 
decay as s"4 following Porod's law for homogeneous particles. The resulting 'shape 
scattering' curve (i.e. scattering due to the excluded volume of the particle with unit 
density) in the range up to s = 2.0 nm"1 was used in the ab initio shape restoration. The 
particle was restored assuming a P222 point symmetry group. The excluded volume of 
the hydrated particle (Porod volume) was computed from the shape scattering curve 






The orientation of the output DAM structure has an arbitrary orientation. Three-
dimensional models of the DAM structure with a model of the NifL PAS domain were 
displayed (Figure 6.4) using the program ASSA[137l The results of the analysis of the 
scattering curves, as well as the experimental and modelling data, are listed in Table 6.1. 
Table 6.1 Experimental and modelling parameters of the NifL PAS domain. 
Mass (kDa) 
E x p e r i m e n t a l 
73-75 " 
M o d e l l i n g 
74 " 
SAXS DAM * 
80 " 
* Parameters of the Dummy Atom Model 
b
 The analytical gel filtration retention time corresponds to a tetrameric protein 
c
 Theoretical value of a tetrameric form of the NifL PAS domain protein, including N-terminal His-tag 
d
 The DAM mass of 1 monomer is 80 / 4 = 20 kDa 
The experimental scattering curves of the A. vinelandii NifL PAS domain are 
presented in Figure 6.3. The initial decay of these curves is linear, indicating a 









Figure 6.3 Experimental scattering curves of the NifL PAS domain from Azotobacter 
vinelandii (1), and calculated scattering patterns from the DAM (2). 
DISCUSSION 
The low resolution solution structure of the A. vinelandii NifL PAS domain protein 
shows a well developed, anisometric shape of four monomers attached to each other. 
This tetrameric form corresponds to the analytical gel filtration experiments that also 
conform a homo-tetrameric state. Fitting of the modelled PAS structure to the global 
solution structure is not straightforward, and several different fits are possible. 
Optimisation of the fit data could be obtained when the three dimensional X-ray 
structure of the NifL PAS domain is elucidated. As can be observed in Figure 6.4, the 
FAD (or actually FMN) cofactor) is buried inside the NifL PAS domain monomers, and 
the FAD phosphate groups have the space to stick out in solution. Small angle X-ray 
scattering measurements of full-length NifL protein might reveal that the tetramerization 
domain is in the PAS domain region. 
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Figure 6.4 Dummy Atom Model (left) of the NifL PAS domain, assuming P222 
symmetry, displayed in 3 different directions. On the basis of the structural homology of 
this domain and the FMN containing phototropin module of Adiantum PHY3 (PDB 
accession number 1G28), four FMN molecules (yellow) were modelled into the 
tetrameric NifL PAS domain model (right). 
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The PAS fold: 
Redefinition 
of the PAS domain 
based upon 
Structural Prediction 
-a Large-Scale Homology Modelling Study-
"Making a model of a horse from photographs does not tell how fast it will run' 
Gutfreund, H. & Knowles, J. R. The foundations of enzyme action 




In the post-genomic era it is essential that protein sequences are annotated correctly 
in order to assign putative functions. Over 1300 proteins in current protein sequence 
databases are predicted to contain a PAS domain based upon amino acid sequence 
alignments. One of the problems with the current annotation of the PAS domain is that 
this domain exhibits limited homology at the amino acid sequence level. From three 
dimensional X-ray and NMR structures available to date, however, it is clear that these 
domains have a conserved three-dimensional fold as shown here by structural alignment 
of six representative 3D structures from the PDB database. Large-scale modelling of the 
PAS sequences present in the PFAM database against the 3D structures of these six 
structural prototypes was performed. All 3D models generated were evaluated using 
Prosall. From our large-scale modelling studies it is clear that the PAS and PAC motifs 
are inseparable and that these two motifs form the PAS fold. The existing subdivision in 
PAS and PAC motifs, as in use by the PFAM and SMART databases, appears to be 
linked to major differences in sequences in the loop region linking these two motifs. This 
loop region, as has been shown by Gardner and co-workers for human PAS kinase'41, is 
very flexible and adopts different conformations depending on the ligand bound. Here 
we propose that this loop region and the adjacent secondary elements are the main 
structural determinants in the biological response of PAS fold proteins. Finally, some 
PAS sequences present in the PFAM database did not produce a good structural model, 
even after realignment using Align-2D, suggesting that these representatives are unlikely 
to have a fold resembling any of the structural prototypes of the PAS domain 
superfamily. 
INTRODUCTION 
In 1997 Zhulin, Taylor and Dixon'3321, and Ponting and Aravind'2311 observed that 
conserved motifs representative of PAS domains were ubiquitous in archaea, bacteria 
and eucarya, and that many PAS containing proteins were involved in the sensing of 
oxygen, redox or light. PAS domains were first found in eukaryotes, and were named 
after homology to the Drosophila period protein (PER), the aryl hydrocarbon receptor 
nuclear translocator protein (ARNT) and the Drosophila single-minded protein (SIM). 
These domains are sometimes referred to as LOV domains; light-, oxygen or voltage 
domains'33'45'49'50' ni\ Unlike many other sensory domains, PAS domains are located in 
the cytoplasm'2871 and are found in serine/threonine kinases'2311, histidine kinases1'1, 
photoreceptors and chemoreceptors for taxis and tropism'2691, cyclic nucleotide 
phosphodiesterases'2661, circadian clock proteins'128' 251], voltage-activated ion 
channels'3161, as well as regulators of responses to hypoxia'1211 and embryological 
development of the central nervous system'2101. Many PAS domains bind cofactors or 
ligands, which are required for the detection of sensory input signals. 
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The first 3D structure determined of a PAS domain containing protein was the 
structure of the Ectothiorhodospira halophila blue-light photoreceptor PYP (photoactive 
yellow protein'27'921). Pellequer and coworkers suggested that PYP is a prototype for the 
three-dimensional fold of the PAS domain superfamily'2261. PYP undergoes a self-
contained light cycle. Light-induced trans-to-cis isomerisation of the 4-hydroxycinnamyl 
chromophore and coupled protein rearrangements produce a new set of active-site 
hydrogen bonds. Resulting changes in shape, hydrogen bonding, and electrostatic 
potential at the protein surface form a likely basis for signal transduction1921. In recent 
years more PAS-like protein structures have been determined. This includes the 3D 
structure of the heme-binding domain of the rhizobial oxygen sensor FixL from 
Bradyrhizobium japonicunP1^, and from Rhizobium melilotP90'. FixL is an oxygen 
sensing histidine protein kinase, forming part of a two-component system that regulates 
symbiotic nitrogen fixation in root nodules of host plants'1901. The PAS domain in FixL is 
a heme-based oxygen sensor that controls the activity of the associated histidine protein 
kinase domain. FixL is regulated by binding of oxygen and other strong-field ligands. 
The heme domain permits kinase activity in the absence of bound ligand, but when the 
appropriate exogenous ligand is bound, this domain turns off kinase activity1971. The 
structural resemblance of the FixL heme domain to PYP indicates the existence of a PAS 
structural motif, although both proteins are functionally different. In addition to the PYP 
and FixL protein structures, other 3D structures recently determined are the N-terminal 
domain of the human ether-a-go-go-related potassium channel HERG (first 3D model of 
a eukaryotic PAS domain'1981), the FMN containing phototropin module of the chimeric 
fern Adiantum photoreceptor'491, and the average NMR structure of the N-terminal PAS 
domain of human PAS kinase'41. The above mentioned protein structures were used as 
structural templates for the homology modelling work described in this paper. 
In order to understand the different mechanisms by which PAS domains mediate 
signal transduction, detailed information about their sequences and structures is needed. 
In the PFAM Protein Families Database'131 there are currently (version 7.8) 958 PAS 
domains present in 607 different proteins. According to PFAM, a PAC motif is found at 
the C-terminus of a subset of the PAS domains. PAS domains are defined differently by 
different authors. The definition used by Zhulin and coworkers'332' comprises a large 
sequence dataset, including SI and S2 boxes. These sensory boxes were initially 
detected in bacterial sensors, and these conserved regions are present in PAS domains in 
all kingdoms of life. The SI and S2 boxes are separated by a sequence of variable length. 
Ponting and Aravind'2311, on the other hand, split this PAS sequence into two separate 
regions; the PAS domain and PAC motif. These two regions roughly correspond to the 
SI and S2 boxes'3321, with varying lengths between the PAS domain and PAC motif. The 
SMART'1481 and PFAM databases use the definition provided by Ponting and Aravind, 
thereby giving rise to an annotation system based upon two domains, PAS and PAC. 
Although the PAC motif is proposed to contribute to the PAS domain structure'2311, 
79 
Chapter 7 
many PAS sequences in the SMART and PFAM databases are not linked to a PAC 
motif, raising the question about possible differences within the PAS domain 
superfamily. The PFAM annotation system is based upon multiple sequence alignments 
and profile Hidden Markov Models (HMM). Although HMM is more sensitive in 
detecting sequence similarities than p. e. BLAST, still HMM based profiles are 
dependent on sequence homology. Problems with HMM based searches may arise when 
proteins have virtually identical 3D structures, but limited sequence similarity. Since 
many protein sequences are emerging from the databases, annotation of these sequences 
should preferably be correct. The availability of the three dimensional structures of 
several PAS domain containing proteins, provide the opportunity to use three 
dimensional information in addition to sequence comparison. Modelling all PAS 
sequences annotated in the PFAM database onto the known PAS structures, results in a 
redefinition of this intriguing family of sensory proteins. 
EXPERIMENTAL PROCEDURES 
Description of the Modelling Templates 
Seven crystal structures127,35'92'93'227,294] and 1 NMR structure'611 are known for the 
photoactive yellow protein (PYP) and PYP mutants from Ectothiorhodospira halophila 
in the Protein Data Bank (PDB)[19]. 
Table 7.1 The six representative structures selected, their Protein Data Bank 



































* Some proteins are not annotated in the SWISS-PROT protein sequence database or its supplement 
TrEMBLl8). Therefore, they are not annotated in the PFAM database. However, PFAM has the possibility 
to BLAST a sequence against their HMM search profile n . 
The structure with accession number 3PYP was chosen as template structure since it 
has the highest resolution (0.85 A)[93l The oxygen sensor FixL has been crystallised 
from two different organisms. We selected from the two Rhizobium meliloti FixL 
structures deposited in the PDB 1EW0[190], as this has the most recent release date, and 
also because the resolution of the two FixL structures is identical. The five different 
PDB files of Bradyrhizobium japonicum FixL[96' 97]) have similar three dimensional 
folds; they are only different with respect to the bound ligand. 1DRM[97] was selected, 
being an apo-protein with the highest resolution (2.4 A). The FMN binding domain 
(1G28[49]) of the fern photoreceptor protein from Adiantum capillus-veneris has a 
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resolution of 2.7 A, and the N-terminal domain of the human-Erg Potassium Channel 
(1BYW[1981) has a resolution of 2.6 A. The last structure used for modelling is the 
average NMR structure of the human PAS kinase N-terminal PAS domain (1LL8)[4]. 
These six representatives are listed in Table 7.1. 
Structural Alignment of the Representative PAS Structures 
The six representative PAS domain structures were aligned structurally using the 
homology module of Insight II (MSI/Biosys, San Diego, California, 1997; version 
2000), running on a Silicon Graphics 0 2 Workstation. The six proteins are compared 
automatically by calculating the root mean square difference between their alpha carbon 
distance matrices. Peptide segments are classified as being conserved when they have 
similar local conformations and similar orientations with respect to the rest of the 
protein. In regions of structural conservation among the proteins, the amino acid 
sequences are aligned, and atom co-ordinates are assigned based upon these alignments. 
Table 7.2 Backbone root mean square deviation values (in Angstrom) of the 
structural ah 
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Alignment Strategy 
All PFAM annotated PAS sequences, including those from proteins containing 
multiple PAS domains, creating a list of 958 PAS sequences. The PFAM alignment of 
the PAS domains was used as initial alignment. All amino-acid residues extending from 
the N-terminal end of the PAS domain were deleted manually, and all sequences were 
extended C-terminally of the PFAM PAS domain in order to incorporate the PAC motif. 
If a sequence had a PFAM annotated PAC motif C-terminal to the PAS domain, the 
corresponding alignment was used. If no PAC motif was present, the sequence was 
elongated to a length similar to the other sequences based upon the genomic information 
available in public databases. This is the best possible option available, as a Hidden 
Markov Model search in PFAM did not result in the assignment of a PAC motif at the C-
terminal end of many PAS domains, most likely due to the limited sequence homology 
to the PFAM HMM defined PAC motif. In this way, an alignment of 958 protein 
sequences was created, with an average length of 105 amino acid residues per sequence. 
Each of the sequences was modelled against all six template structures representative for 
the PAS fold. 
The PAS and PAC annotated sequences of four organisms were studied in greater 
detail. All PAS annotated sequences from Arabidopsis thaliana, Escherichia coli, 
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Azotobacter vinelandii and Caenorhabditis elegans were re-aligned using the Align-2D 
command within MODELLER version 6.2 (Table 7.3). This enables the alignment of a 
sequence with a structure in comparative modelling, as amino acid sequence gaps are 
placed in a better structural context, and could improve the alignments provided by 
PFAM . There are eight PFAM PAC annotated sequences in these four organisms, 
which lack a PAS domain N-terminally of the PAC motif. These sequences were 
elongated N-terminally, to incorporate a possible PAS region present. The PAC 
alignment as present in the PFAM database, was not changed, and the N-terminal region 
was aligned manually. Also these sequences were re-alignment using Align-2D. These 
sequences and the modelling results are listed in Table 7.4. 
Homology Modelling 
Models of all 958 PAS containing sequences were generated using MODELLER 
version 6.2[2'77,1591 running on a dual processor Xeon 1.7 GHz Pentium computer with 1 
Gb RAM, with REDHAT Linux release 7.3. The average calculation time for one model 
was about 90 seconds, resulting in six days of computer calculations. To optimise CPU 
usage, not more than 3 MODELLER jobs were running at the same time. For the 
resulting 6*958 protein models, the Prosa z-score was calculated using Prosall version 
3.0[262l MODELLER is an implementation of an automated approach to comparative 
structure modelling by satisfaction of spatial restraints. As input it requires an alignment 
file and a pdb-file of the template structure. As output it generates a pdb-file of the 
model. Default settings were used, and the molecular dynamics refinement level was set 
to 2. The Align-2D command in MODELLER aligns a block of sequences with a block 
of structures, using a variable gap opening penalty. This gap penalty can favour gaps in 
exposed regions, and avoid gaps within secondary structure elements. The Align-2D 
command can be used to try to improve the existing alignment, but does not always 
result in a better quality of the 3D model generated. 
RESULTS 
Alignment of Existing Structures 
Six structures were chosen (listed in Table 7.1) as representatives of the 19 PAS 
domain structures in the PDB database for comparative analysis. The other 13 structures 
(mutants or structures containing a different cofactor) have very similar 3D structures as 
the six representatives. Of these six structures, all N- and C-terminal amino acid residues 
that did not align after superimposition (Figure 7.1 A) were removed from the 
corresponding alignment file manually (Figure 7.ID). The alignment obtained 
incorporates the two previously identified regions, the PFAM PAS and PAC motifs (The 
areas on which the structural alignment is based, is indicated with a black bar below the 
sequence alignment in Figure 7.ID). In this way, the sequences were trimmed back to a 
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sequence length in which the common fold observed was equivalent for all six proteins. 
The root mean-square deviation for this alignment is 1.25 A, indicating high structural 
overlap. As some structures are more closely related than others, Table 7.2 shows the 
partial root mean-square deviations for all six structures, as well as the global root mean-
square deviation. 
Figure 7.1 An overlay of the structural alignment of the six representative PAS 
structures selected is presented in panel A. The PFAM PAS annotated regions are 
coloured in blue, the PAC motif regions in orange/red. Structures and part of structures 
currently not assigned as either PAS or PAC are coloured in grey. Panel B shows the 20 
lowest-energy solution structures of the human PAS kinase. In panel C a schematic 
representation of the human PAS kinase (according to[4]) is given. The flexible region 
between Fa and Gp is clearly visible in B. This loop is located between the PAS domain 
and PAC motif. Panel D shows the structural alignment of the six structures selected. 
The PAS domains are indicated with blue bars, the PAC motifs with orange bars. The 
boxes on which the structural alignment is based are indicated in black. Helical and sheet 
region residues are coloured in red and yellow, respectively. 
The 20 lowest-energy NMR solution structures of the human PAS kinase are shown 
in Figure 7.IB. The majority of the human PAS kinase structure was solved with high 
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precision, but portions of the Fa helix and the subsequent FG loop were poorly defined 
in this structural ensemble[41. The Fa helix and the FG loop correspond to that region of 
the PAS fold, which tethers the PAS domain and PAC motif. A schematic representation 
of the human PAS kinase is depicted in Figure 7.1C. 
The other PAS domain containing structures resemble a similar fold, in which the 
area corresponding to the Fa helix and the subsequent FG loop of human PAS kinase is 
believed to form specific interactions in the hydrophobic core or with bound cofactors. 
The FixL structures have elevated temperature factors in the FG loop region, indicating 
increased flexibility'97' 191l The FG loop might be the key flexible region necessary for 
signal transduction141. 
According to the PFAM Protein Families Database'131, not all six structures contain 
both a PAS (PF00989) and a PAC motif (PF00785) (see Table 7.1). (in Figure 7.1D the 
PAS annotated domains are coloured with blue bars, and the PAC annotated domains 
with orange bars). It is obvious from the structural overlay in Figure 7.1A, that all six 
proteins share a common domain with a characteristic 5-stranded P-pleated a-helical 
structure. In comparing the structural and sequence alignments, it is clear that the 
subdivision of the domain into PAS and PAC motifs is incorrect, since their existence 
would imply that the conserved 5-stranded P-sheet is split into two sections. Therefore 
we propose to use the name PAS fold'226' 287] for the complete P-pleated a-helical 
structure, which defines PAS domains and C-terminal PAC motifs in terms of structure 
rather than sequence. 
Large-Scale Modelling 
The first, and most critical, step in protein homology modelling is the appropriate 
alignment of template and experimental sequences. The alignment of the six 
representative 3D structures (Figure 7.1 A and 7.ID) provides the possibility to use all 
six structures as template for large-scale homology modelling. Note that not all six 
structures contain a PAS as well as a PAC motif, according to the PFAM database 
(Figure 7.ID and Table 7.1). Each of the 958 PAS domains was modelled against each 
of the 6 template structures presented in Figure 7.1. Prosall Z-scores were sorted by 
template structure, resulting in good- and bad models. With an average sequence length 
of 105 amino acid residues, all models with a z-score higher than -3.57 (that is, closer to 
zero) were considered to be poor models'2471, and were rejected. Thus, 30 % of the 
sequences used did not produce a good quality model. Of the resulting 672 best models, 
188 were constructed using 1EW0 as template, and 177 were constructed using 1DRM. 
Only 2.2 % of the best models used 1LL8 as template. A pie-diagram of these results is 
depicted in Figure 7.2. Notably, 1EW0 and 1DRM were the best template structures, 
each in about 27 % of the cases. This might indicate that most PAS domain proteins 
would resemble a fold similar to FixL. A list of all PAS sequences modelled, as well as 
their best template structure, will be distributed on our website in near future. 
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Table 7.3 All sequences of the model organisms annotated in the PFAM PAS 
domain alignment. The presence of any adjacent PFAM PAC annotated domain is listed. 
For each sequence the template sequence with the best E-value is given, as well as the z-























nonphototropic hypocotyl protein 1 
nonphototropic hypocotyl protein 1 
putative ser/thr kinase 
putative ser/thr kinase 
nonphototropic hypocotyl protein 2 
nonphototropic hypocotyl protein 2 
putative ser/thr kinase 
putative protein kinase 
putative protein kinase 
putative protein kinase 
putative protein kinase 






































































































































































sensor protein atoS 
sensor protein dcuS 
hypothetical protein yegE 
hypothetical protein yegE 
hypothetical protein yciR 
sensor kinase dpiB 
TraJ protein 
TraJ protein 
phosphate regulon sensor phoR 
aerobic respiration control sensor 
arcB 
hypothetical protein yddu 
hypothetical protein yddu 






































































































aryl hydrocarbon receptor nuclear 
translocator ortholoq 1 
aryl hydrocarbon receptor nuclear 
translocator ortholoq 1 
aryl hydrocarbon receptor ortholog 1 







putative transcription factor 
C15C8.2 
putative transcription factor 
C15C8.2 





























































































nitrogen fixation regulator NifL 















* PFAM has the possibility to BLAST a sequence against their HMM search profile. Some sequences (*) 
are then annotated as PAC motif. 
* Some sequences are annotated as having a PFAM-B region (B66903 or B39648 or B19516). PFAM-
B regions contains a large number of small families that do not overlap with PFAM-A. Although of lower 
quality PFAM-B families can be useful when no PFAM-A families are found. 
Arctbidopsis, Escherichia, Caenorhabditis, and Azotobacter; a case study 
Some of the PAS domains have been analysed in detail. We chose four representative 
organisms from the animal, bacterial and plant kingdoms, Arabidopsis thaliana, 
Escherichia coli, Azotobacter vinelandii and Caenorhabditis elegans, to analyse their 
complement of PAS domains. These species have been studied extensively and many 
details of their gene expression and function are known. 
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All PAS domains 
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Figure 7.2 On the top-left a pie-diagram of the percentage best model, for each of the 
672 best models, is presented. Of the 6 template structures used, 54 % of the sequences 
gives a best model with the FixL (1DRM and 1EW0) structures as template structure, 
while only a small percentage of the best models is created by using 1LL8 as template 
structure. The subsequent pie-diagrams of the percentage best model, for all PFAM PAS 
annotated A. thaliana, C. elegans, and E. coli sequences are shown. On average, for 
these three model organisms, 32 % of the sequences gives a best model with the 1EW0 
as template structure, while only 3 % of the best models is created by using 1LL8 as 
template structure. Note that for the latter three, only a limited number of sequences is 
modelled. 
The existing PFAM PAC annotation of sequences from these organisms is listed in 
Table 7.3. However, some sequences with a PAC motif are not annotated as having a 
PAS domain (Table 7.4). The full-length sequences of these proteins were aligned 
manually, and subsequently trimmed back to the region which we denote as representing 
the PAS fold. Alignment of this region from the A. thaliana sequences listed in Table 7.3 
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and Table 7.4, based upon the structural alignment (Figure 7.ID) of the six 
representative PAS proteins, is depicted in Figure 7.3. We conclude from this alignment 
that all PAS annotated A. thaliana proteins also contain a PAC motif, and conversely 
that all PAC annotated A. thaliana proteins contain a PAS domain. Therefore, in the case 
of A. thaliana, the PAS and PAC motifs are not separable, indicating that annotation of 
these proteins as containing only PAS or PAC motifs is questionable. A similar 
realignment was performed with the other three organisms, resulting in the same 
conclusion: PAS and PAC motifs do not occur independently of each other, but are parts 
of the same functional fold, separated by a linker region which is flexible in length. As 
all sequences of the four organisms studied showed inseparable PAC and PAS regions, 
the coexistence of PAS and PAC motifs might also apply to most other PAS and PAC 
protein sequences present in the PFAM database. 
The sequences of these proteins were also re-aligned using the Align-2D command[2], 
in order to try to improve the manual alignment. Modelling based upon these alignments 
sometimes resulted in higher z-scores, and thus better models, as listed in Table 7.3. 
Indeed, some of the low-scoring models had a better z-score after realignment, resulting 
in more reliable models. This was specially the case for the A. thaliana phytochromes. 
The PFAM PAC motif annotated sequences, that do not have a PFAM PAS annotation, 
also gave reasonable z-scores after realignment (Table 7.4). 
It is interesting to consider whether the best template for modelling a particular PAS 
domain is related to the co-factor which it contains. Unfortunately there are insufficient 
PAS domains characterised at the biochemical level to make any definitive correlation. 
The NifL PAS fold (amino acid residues 36-144) from A. vinelandii binds FAD as 
cofactor1"61. The best template was 1G28 (Table 7.3), a FMN binding PAS fold protein. 
The second PAS fold in this protein (amino acid residues 162-268) gives the best model 
when using the heme containing FixL X-ray structure 1DRM (Table 7.3). There is some 
indication that this domain indeed binds heme (R. Dixon, unpublished results). 
PA C annotated sequences 
Eight protein sequences from A. thaliana, E. coli, and C. elegans do not contain a 
PAS domain but only a PAC motif according to PFAM . All 8 sequences yielded reliable 
models, judged by their Prosall z-scores (Table 7.4). For example, the E. coli Aerotaxis 
receptor (P50466) is described as containing a PAS domain by Ponting and 
coworkers'231' 332], although it is not annotated as such in the PFAM database. This 
protein has FAD as cofactor[21]. 
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Figure 7.3 Alignment of all A. thaliana sequences that are either annotated as PFAM 
PAS domain or PFAM PAC motif. Amino acid residues having a sequence similarity > 
35 % are depicted in black shading. In the left column the SWISS-PROT or TrEMBL 
accession numbers are listed, in the adjacent column the first and the last amino acid 




Table 7.4 Sequences that have a PFAM PAC annotation, but not a PFAM PAS 
annotation, were extended N-terminally to incorporate any available PAS domain. The 
N-terminal region of these sequences were aligned manually, and the sequences were 
subsequently modelled against the six template structures. Realignment with Align-2D 
















































































The two C. elegans sequences listed in Table 7.4 were derived from different strains, 
and differ only in one amino acid residue. This mutation is not in the PAS fold region, 
and therefore both protein sequences give the same result. Both 3D models were very 
reliable over the complete PAS fold sequence length. More examples of sequences that 
are (almost) identical are present in the PFAM PAS database (for instance the C. elegans 
sequences 002219 and 044711). 
DISCUSSION 
In the PFAM database there are amino acid sequences of almost 1000 PAS domains 
representative of all kingdoms of life. Of all PAS domain containing proteins present in 
the PDB database it can be concluded that the PAS and PAC motifs split the 5-stranded 
P-sheet into two sections. The PAS and PAC motifs are connected through a loop region, 
which was recently suggested to be important for the intrinsic function of PAS domain 
containing proteins. It is evident from the 3D structures present in the database, and from 
our large scale modelling studies presented here, that the PAS and PAC motif are 
inseparable and together give rise to a structural fold. In order to avoid confusion in 
protein annotation, it is important to define the sequence requirements for a given protein 
fold. We propose to define the complete P-pleated a-helical structure observed in the 
prototype structures of the PYP, FixL, human PAS kinase, HERG, and PHY3 proteins as 
the PAS fold. For comparison of proteins it is necessary to abandon the use of the 
commonly used annotations SI / S2[332], PAS-A / PAS-B[48, U7], LOV domain[33' M\ and 
PAS domain / PAC motif123'1 which are now in use to specify sequence similarities. 
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Unfortunately in recent years the meaning of the term "PAS domain" has evolved. We 
favour the use of the term "PAS fold" for referring to proteins sharing the PAS structural 
element rather than a sequence alignment. 
For the large-scale homology studies, the existing PFAM PAS domain alignment was 
extended C-terminally by 50 amino acids in order to include the neighbouring PAC 
motif. Our studies show that sequence comparison alone is no longer sufficient to 
annotate newly discovered protein sequences as having a PAS domain, and we 
demonstrate that modelling studies give more insight into this intriguing family of 
sensory proteins, since 30 % of the PAS domains annotated in the PFAM database are 
unlikely to share the "PAS fold" as defined in this article. After re-alignment of PAS 
annotated protein sequences from four model organisms, some 3D models improved in 
quality, while others did not. The Align-2D command used for this realignment, could be 
of help in improving sequence alignments, but is not always successful. For the four 
organisms studied extensively, the drop-out percentage for bad models decreased 
significantly, from 21 % to 12 % (Figure 7.2). To date, three dimensional structures of 
six different PAS proteins have been elucidated. When more structures of PAS fold 
containing proteins will become available, it will be possible to redefine the PAS fold 
containing proteins into several subclasses, depending upon template structure or 
cofactor. 
The PAS fold represents an important sensory domain present in all kingdoms of 
life'3321, and in the PFAM database some proteins appear to have more than one PAS 
domain. Some proteins are known to contain two flavin cofactors'215'314], or both a flavin 
and a heme'206'249], though they do not contain a PAS fold. In the PFAM database there 
are currently four proteins each having five (partial) PAS annotated domains'125'126'212' 
274)
. The 20 PFAM PAS annotated regions have been modelled against the six 
representative PAS structures. This reveals that 50 % of the models have a poor z-score, 
and they are rejected as a reliable model. This percentage is significantly higher that the 
percentage rejected models for all PFAM PAS annotated sequences (30 %). A possible 
explanation is that of the 20 regions annotated as PAS, 14 are annotated as partial PAS 
domain. Furthermore, not all PAS regions are followed C-terminally by a PAC motif. 
Purification and subsequent structure analysis of these proteins might reveal the real 
number of PAS folds per protein. 
All models of sequences of the four organisms used in the case study, which had a 
PFAM PAS domain annotation, had reliable z-scores, even if no PFAM PAC motif was 
present. Even more striking, all models of sequences with only a PFAM PAC motif 
annotation had good z-scores as well. This stresses the importance of better annotation of 
the PAS fold, based upon structural information rather than sequence information. 
Annotation of protein sequences by PFAM (and SMART) is based upon sequence 
homology and HMM profiles. This annotation system is of great use for researchers, as 
for many protein sequences, a potential function based upon this annotation system can 
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be assigned. However, when proteins have only a limited sequence homology (as is the 
case for the PFAM PAC motifs), annotation of these motifs is difficult even using 
Hidden Markov Model. We show here that large scale homology modelling can be very 
useful in addition to HMM-based sequence annotation on the basis of a detailed analysis 
of all PAS and PAC sequences present in the PFAM database for A. thaliana, E. coli, C. 




"All models are wrong, but some are useful" 
Zeger, S. L. Statistical reasoning in epidemiology 
American Journal of Epidemiology 134, 1062-1066 (1991) 
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The main goal of this Ph.D. project was to obtain insight into the structure and 
function of the nitrogen fixation regulatory protein NifL from Azotobacter vinelandii. 
Nitrogen fixing bacteria, such as A. vinelandii, are capable to convert N2 to NH3. This 
conversion is essential for live, since animals and plants need NH3 for their existence, 
and are unable to perform this conversion. The biosynthesis of NH3 is controlled by 15 
to 20 different nitrogen fixation (nif) gene products. The activation of nif gene 
expression by the transcriptional regulatory enhancer binding protein NifA is controlled 
by the sensor flavoprotein NifL in response to changes in oxygen level or the level of 
fixed nitrogen. The N-terminal domain of NifL contains two PAS domains. PAS 
domains are ubiquitous motifs present in archaea, bacteria and eucarya, and are named 
after the first letters of the Drosophila Period protein (PER), the Aryl hydrocarbon 
receptor nuclear translocator protein (ARNT) and the Drosophila Single-minded protein 
(SIM). For understanding the different mechanisms in which PAS domains work 
detailed information about their cofactor binding region is needed. The cofactor of the 
N-terminally located PAS domain from NifL is shown to be FAD. To tackle the fold and 
function of this region, it is of interest to deflavinate and reconstitute this domain. 
A review article has been written (Chapter 2), summarising the advances made in the 
field of flavoprotein deflavination and reconstitution. Conventional precipitation 
methods, such as the acid ammonium sulfate procedure, are rapid but the yield and 
reconstitutability of apoprotein may vary dramatically. The more recently developed 
chromatographic procedures have the advantage that the apoprotein is stabilised by 
immobilisation, and that large amounts of apo- or reconstituted flavoproteins can be 
obtained. These chromatographic procedures can combine the use of affinity tags both 
for the purification of the protein of interest as well as replacement of the protein-bound 
cofactor. If the cofactor is covalently bound, protein engineering provides insight into 
the mechanism of covalent flavinylation. Site-directed mutagenesis can also be used to 
change the strength of the flavin-apoprotein interaction. As several diseases are 
associated with mutations in human flavoprotein genes, understanding the flavin-
apoprotein interaction is also of medical relevance. An example of the use of affinity 
tags for the deflavination and reconstitution of the NifL PAS domain protein is given in 
Chapter 4. 
Because imidazole can influence crystallographic trials, a general procedure for the 
purification of His-tagged proteins has been developed (Chapter 3). The high selectivity 
of IMAC column material towards histidine-tags, combined with on-column removal of 
the tag with thrombin results in a two-step purification with high overall yield. 
Moreover, this method has the advantage that instead of imidazole, thrombin is used in 
the final purification step. Removal of the His-tag results in a protein with no additional 
tags, except three additional amino acids at the N-terminal side. This structure resembles 
therefore the native form of the protein. It proved to be very successful for the NifL PAS 
domain, as well as for three other His-tagged proteins. The proof that imidazole can 
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prevent crystallisation of proteins, even when it is present in small amounts, is that in the 
case of the NifL PAS domain, the His-tagged protein never crystallised, though the non-
tagged version did. This, of course, could also be caused by the removal of this very 
hydrophilic tag. 
Although removal of the His-tag leads to protein free of imidazole traces, the tag 
itself can be used for the preparation and reconstitution of apoflavoproteins. A method is 
described in Chapter 4, in which the His-tag is used to prepare apoprotein or protein 
reconstituted with either 2,4a-13C-FAD or 2,4a-13C-FMN. The His-tagged NifL PAS 
domain holoprotein is bound to an immobilised metal affinity column, and the flavin is 
released by washing the column with buffer containing 2 M KBr and 2 M urea. The 
apoprotein is reconstituted on-column with the (artificial) flavin cofactor, and then eluted 
with buffer containing 250 mM imidazole. Alternatively, the immobilised apoprotein can 
be released from the column matrix before reconstitution. The advantage of this method 
is that it combines a protein affinity chromatography technique with limited protein loss. 
This results in a high protein yield with extremely efficient flavin reconstitution, and 
may develop as a universal method for replacement of flavin or other cofactors. 
The non-tagged NifL PAS domain protein, purified as described in Chapter 3, is 
crystallised by the hanging-drop vapour-diffusion method. The crystals belong to the 
rhombohedral spacegroup R32, and native data were collected to 3.0 A on the BW7B 
synchrotron beamline at the EMBL Hamburg Outstation. Initial attempts to crystallise 
Se-Met incorporated protein crystals were unsuccessful. Structure elucidation using 
molecular replacement strategies seems to be successful, and preliminary data of the 
partially elucidated structure is presented in Chapter 5. It is questionable as whether this 
model can be refined to a satisfactory R-factor, as this is an ongoing project. 
The tagged version of the NifL PAS domain protein was examined by synchrotron 
small-angle X-ray solution scattering (Chapter 6). The experimental scattering data leads 
to a global fold of the tetrameric domain at low-resolution. Fitting a model of the PAS 
domain to this dummy atom model leads to a better understanding of the dimerisation / 
tetramerisation interface. The resulting low resolution structure of the NifL PAS domain 
shows a well developed, anisometric shape of four monomers attached to each other. 
This tetrameric form is in agreement with analytical gel filtration experiments which also 
conform a homo-tetrameric state of this domain. Small angle X-ray scattering 
measurements of full-length NifL protein might reveal that the tetramerization domain is 
in the PAS domain region. 
One of the problems with the current annotation of the PAS domain is that this 
domain exhibits limited homology at the sequence level. From 3D X-ray and NMR 
structures available to date, however, it is clear that these domains have a conserved 
three-dimensional fold as shown by structural alignment of six representative 3D 
structures from the PDB database (Chapter 7). Large-scale modelling of the PAS 
sequences present in the PFAM database against the 3D structures of these six structural 
95 
Chapter 8 
prototypes was performed. The existing subdivision into PAS and PAC motifs, as in use 
by the PFAM and SMART databases, appears to be linked to major differences in 
sequences in the loop region linking these two motifs. This loop region is very flexible 
and adopts different conformations depending on the ligand bound. We propose that this 
loop region and the adjacent secondary elements are the main structural determinants in 
the biological response of PAS fold proteins. Finally, some sequences did not produce a 
good structural model, even after realignment using Align-2D, suggesting that these 
representatives are unlikely to have a fold resembling that of any of the structural 
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Dit proefschrift is het resultaat van een onderzoeksprqject uitgevoerd in Europees 
verband. Een van de belangrijkste doelen van dit project was om inzicht te krijgen in de 
structuur en de functie van het eiwit genaamd NifL. Dit eiwit, dat stikstof-fixatie 
reguleert, komt van nature voor in Azotobacter vinelandii. A. vinelandii is een bacterie 
die in de bodem leeft, en deze bacterie heeft het vermogen om het gas stikstof (N2) om te 
zetten in ammoniak (NH3). Deze omzetting is van essentieel belang voor het leven op 
aarde, omdat dieren en planten ammoniak nodig hebben voor hun bestaan, maar hogere 
organismen zijn niet in staat zijn om stikstof naar ammoniak om te zetten. De 
biosynthese van ammoniak, uitgevoerd door A. vinelandii, wordt gereguleerd door 15 tot 
20 verschillende stikstof fixatie (nij) gen-producten. De activering van deze nif gen 
expressie wordt verzorgd door het eiwit NifA. NifL, op zijn beurt, reguleert NifA. NifL 
is een sensor eiwit dat een flavine cofactor bevat. 
Het N-terminale deel van NifL bevat twee PAS domeinen. PAS domeinen zijn 
veelvoorkomende eiwit motieven, en komen voor in bacteria, eukaryoten en archea. De 
naam PAS is afgeleid van de eerste letters van het Period eiwit, het Aryl hydrocarbon 
receptor nuclear translocator eiwit, en het Single minded eiwit. Om meer te leren over 
de verschillende werkingsmechanismen van PAS domeinen, is het nodig om meer 
inzicht te krijgen in dat deel van deze eiwitten dat betrokken is bij de interactie met 
cofactoren. De cofactor van het N-terminale PAS domein in NifL is FAD. Om de 
vouwing en de functie van dit deel van het eiwit te achterhalen, is het interessant om 
deze flavine cofactor te verwijderen en te vervangen door analoge cofactoren. 
In Hoofdstuk 2 wordt een overzicht gegeven op het gebied van het verwijderen en 
vervangen van de cofactoren in flavine bevattende eiwitten. Conventionele precipitatie 
methoden, zoals bijvoorbeeld de zure ammonium sulfaat methode, zijn erg snel. Helaas 
valt de opbrengst vaak tegen, de reconstitutie van het apo-eiwit met een andere cofactor 
lukt niet altijd. Verder wordt in dit hoofdstuk ingegaan op modernere technieken. Deze 
technieken hebben het voordeel dat het apo-eiwit wordt gestabiliseerd doordat het 
geiimmobiliseerd is, zodat grote hoeveelheden apo- of gereconstitueerd eiwit verkregen 
wordt. Deze chromatografische methoden combineren het gebruik van een affiniteits 
staart zowel voor de zuivering van het gewenste eiwit alsook voor de vervanging van de 
eiwit-gebonden cofactor. Wanneer deze cofactor covalent gebonden is aan het eiwit, dan 
kan met behulp van protein engineering (het veranderen van de aminozuur sequentie van 
een eiwit door middel van mutaties) inzicht worden verkregen in dit 
bindingsmechanisme. Site-directed mutagenesis (het aanbrengen van mutaties in de 
eiwitsequentie) wordt ook wel gebruikt om de bindingssterkte tussen de cofactor en het 
eiwit te varieren. Sommige humane ziektes worden veroorzaakt door veranderingen in 
de aminozuur sequentie van flavine eiwitten. Meer inzicht in eiwit - cofactor interacties 
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is dus ook medisch gezien interessant. Een voorbeeld van het gebruik van deze affiniteits 
staartjes voor het verwijderen en vervangen van flavine cofactoren in eiwitten wordt 
gegeven in Hoofdstuk 4, hier wordt het NifL PAS domein eiwit gebruikt. 
Imidazool kan een effect hebben op kristallisatie pogingen. Om dit te voorkomen is 
een algemene methode ontwikkeld voor de zuivering van eiwitten met een histidine 
staartje (Hoofdstuk 3). IMAC kolommen hebben een hoge specificiteit ten aanzien van 
histidine staartjes, waardoor deze kolommen uitermate geschikt zijn voor de zuivering 
van eiwitten met zo'n staart. Een efficiente tweestaps zuiveringsmethode kan worden 
verkregen door met behulp van het enzym thrombine deze staart te verwijderen van het 
eiwit, terwijl deze nog vast zit aan de kolom. Behalve een grotere efficientie heeft deze 
methode nog een groot voordeel: in de laatste stap wordt geen imidazool meer gebruikt, 
maar thrombine. Hierdoor wordt bovendien ook nog de toegevoegde histidine staart 
verwijderd, zodat het eiwit meer lijkt op het oorspronkelijke, natuurlijke, eiwit. Deze 
methode is succesvol getest op 4 verschillende eiwitten, waaronder het NifL PAS 
domein eiwit. Zoals aangegeven kan imidazool, zelfs in kleine hoeveelheden, een 
verstorend effect hebben op de kristallisatie van eiwitten. In het geval van het NifL PAS 
domein bijvoorbeeld, kristalliseerde de vorm waarin de histidine staart aanwezig was 
niet, maar de staartloze versie wel. Dit kan natuurlijk ook komen doordat deze hydrofiele 
staart niet meer aanwezig was. 
Alhoewel het verwijderen van de histidine staart leidt tot eiwit dat vrij is van 
imidazool sporen, kan de staart zelf ook voordelen hebben voor het verwijderen en 
vervangen van de flavine cofactor. In Hoofdstuk 4 is een methode beschreven waarbij de 
histidine staart wordt gebruikt voor het verwijderen van de FAD cofactor, en voor het 
verkrijgen van FAD of FMN wat met een koolstof-isotoop is gelabeld (2,4a-13C-FAD en 
2,4a-13C-FMN). Nadat het NifL PAS domein met daaraan de histidine staart is gebonden 
aan een gei'mmobiliseerde metaal affiniteits kolom, kan de flavine cofactor worden 
verwijderd door de kolom te wassen met een buffer waarin 2 molair kaliumbromide en 2 
molair urea is opgelost. Het zo ontstane apo-eiwit kan, terwijl het aan de kolom 
gebonden is, worden gereconstitueerd met een artificiele flavine cofactor. Hierna kan dit 
gereconstitueerde eiwit van de kolom kan worden gehaald door te wassen met een buffer 
waarin 250 millimolair imidazool is opgelost. In plaats van reconstitutie, kan het apo-
eiwit ook van de kolom verwijderd worden. Het voordeel van deze eiwit affiniteits 
chromatografie techniek is dat er weinig eiwit verloren raakt. Het resultaat is een erg 
hoge eiwit opbrengst, gecombineerd met een erg efficiente flavine reconstitutie. Deze 
techniek zou zich dan ook kunnen ontwikkelen tot een universele methode voor het 
vervangen van flavine of andere cofactoren. 
Het staartloze NifL PAS domein, zoals gezuiverd in Hoofdstuk 3, kan kristalliseren 
met behulp van de hanging-drop vapour diffusion methode. Bij deze methode hangt het 
eiwit als een druppeltje aan een glasplaatje boven een vloeistofoplossing. Door middel 
van verdamping treedt een evenwichtssituatie op, waarbij de concentratie eiwit zover 
102 
Samenvatting 
toeneemt dat deze uiteindelijk neer zal slaan in de vorm van een kristal. De zo ontstane 
kristallen behoren tot de rhombohedrische kristalgroep K52, en natieve data tot een 
resolutie van 3 Angstrom werden gemeten met behulp van de BW7B synchrotron 
deeltjesversneller die staat bij het EMBL in Hamburg. Pogingen om het eiwit te labelen 
met selenomethionine en vervolgens te kristalliseren mislukte, maar de 
structuuropheldering door middel van de molecular replacement aanpak lijkt succesvol. 
Preliminaire resultaten van de gedeeltelijke structuuropheldering worden getoond in 
Hoofdstuk 5. Dit is een nog lopend project, en op dit moment is nog niet duidelijk of 
deze gedeeltelijke structuur ook zal leiden tot een uiteindelijke kristalstructuur. 
De vorm van het eiwit waaraan de histidine staart nog gebonden was is bestudeerd 
met behulp van synchrotron small-angle X-ray solution scattering (Hoofdstuk 6). 
Synchrotron rontgen straling wordt verstrooid door eiwit in oplossing, en hieruit kan een 
globale vouwing van het tetramere eiwit worden berekend. Door een eiwit model te 
fitten tegen dit lage-resolutie model, kan inzicht worden verkregen over hoe de 
dimerisatie en tetramerisatie vlakken emit zien. Het resultaat is een lage-resolutie 
structuur van het NifL PAS domein als een tetrameer, en dit tetramere model bevestigt 
analytische gel filtratie experimenten waaruit ook een tetramere opbouw van het domein 
bleek. Als men Small-angle X-ray verstrooiings metingen zou verrichten met het hele 
NifL eiwit, dan zou kunnen blijken dat het PAS domein de oorzaak is van tetramerisatie 
van het hele eiwit. 
Een van de problemen die ontstaan door de huidige annotatie van PAS domeinen is 
dat dit domein een beperkte sequentie homologie heeft. Door driedimensionale 
kristalstructuren en NMR structuren te bestuderen van 6 eiwitten, blijkt dat deze eiwitten 
een geconserveerde driedimensionale vouwing hebben (Hoofdstuk 7). Alle PAS 
geannoteerde eiwit sequenties uit de PFAM database zijn gemodelleerd tegen deze 6 
structurele PAS prototypes. De huidige onderverdeling in PAS en PAC motieven, zoals 
die ook in gebruik is in de PFAM en SMART databases, lijkt gecorreleerd te zijn met 
belangrijke verschillen in de lus-regio die deze twee motieven verbindt. Dit flexibele 
stuk eiwit kan zich op verschillende manieren vouwen, afhankelijk van het ligand dat 
gebonden is. We stellen dan ook voor zowel dit flexibele deel, alsook de twee 
aanliggende motieven, de naam 'PAS fold' te geven, aangezien ze gezamenlijk een 
belangrijk structureel element vormt die betrokken is bij de biologische interacties zoals 
PAS eiwitten die kunnen aangaan. Tot slot wordt in dit hoofdstuk nog ingegaan op een 
aantal eiwitten die niet goed gemodelleerd kunnen worden, en dus mogelijk geen 
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